Plant-Based Vegan Meals the Law in California Hospitals and Prisons

Gov. Jerry Brown Makes Plant-Based Meals the Law in California Hospitals.

 

SB 1138 will require licensed California health care facilities and state prisons to make available plant-based meal options containing no animal products or by-products, including meat, poultry, fish, dairy, or eggs.

————————————————

The Physicians Committee—a nonprofit with 12,000 doctor members—applauds California Gov. Jerry Brown for signing into law a landmark bill that guarantees patients a healthful plant-based option at every meal. Sen. Nancy Skinner (D-Berkeley) authored Senate Bill 1138, which was co-sponsored by the Physicians Committee and Social Compassion in Legislation.

“Whether to protect animals, our climate or our health, those of us who choose to eat a vegan diet can celebrate today with Gov. Brown’s signing of SB 1138,” says Sen. Skinner. “SB 1138 ensures that people in hospitals, healthcare facilities, or prison have access to plant-based meals.”

SB 1138 will require licensed California health care facilities and state prisons to make available plant-based meal options containing no animal products or by-products, including meat, poultry, fish, dairy, or eggs.

 

“We are elated that Gov. Brown sees the value in requiring plant-based meals in prisons and medical facilities,” says Judie Mancuso, president and founder of Social Compassion in Legislation, which co-sponsored the bill. “Plant-based foods are key to better health outcomes, fighting climate change, and reducing the number of animals in our food production.”

In June 2017, the American Medical Association passed a Healthy Food Options in Hospitals resolution that calls on U.S. hospitals to improve the health of patients, staff, and visitors by providing plant-based meals. The American College of Cardiology made the same recommendation in Planting a Seed: Heart-Healthy Food Recommendations for Hospitals.

“Thanks to Sen. Nancy Skinner and Gov. Jerry Brown for passing this historic law that will provide plant-based options to hospital patients looking to fight heart disease, diabetes, and obesity—or who simply want a more healthful meal,” says Physicians Committee president Neal Barnard, M.D., F.A.C.C. “Now, it’s time for California hospitals to start putting into practice the plant-based meals recommended by the American Medical Association and the American College of Cardiology.”

 

The Physicians Committee’s Healthy Food in Health Care web page provides quantity plant-based recipes, tips for implementing plant-based meals, and case studies of hospitals championing healthy food.

St. Joseph Health System in Sonoma County, Calif., reports, “Vegetarian entrées cost about 50 percent less than meat entrées.” The hospital projects saving $5,000 a year by serving more meat-free meals.

 

 

To learn more about a plant-based alkaline vegan diet read The pH Miracle Revised and Updated by Robert O. Young DSc. PhD. http://www.drrobertyoung.com and http://www.phmiracleretreat.com, http://www.ijuicenow.com, http://www.phoreveryoung.com, http://www.phmiracle.com, http://www.phwisdom.com, http://www.alkalinecare.com, http://www.phmiraclestore.com, http://www.innerlightblue.com

———————————————

HEALTH WARNING to ALL WOMEN & NOW MEN!

Inflammatory Ductal Cell Carcinoma with a 14.3cm Vascular Tumor Mass
Inflammatory Ductal Cell Carcinoma with a 14.3cm Vascular Tumor Mass

20 Acidic Cancerous Symptomologies of the BREAST TISSUES that Women and NOW MEN NEED to UNDERSTAND and Do Something About NOW!

The thermography pictures above is of Valentino, a Russian woman from Moscow who was diagnosed with Inflammatory Ductal Cell Carcinoma with a 14.3cm tumor mass in the left breast. Each week we took thermography and Ultrasound pictures of her progress and in the seventh week the cancerous tumor mass was gone and the breast tissue was non-cancerous. She followed Robert O. Young’s self-care to a self-cure, pH Miracle for Cancer protocol and reversed her medically diagnosed Ductal Cell Carcinoma in 7 weeks without chemotherapy, radiation or surgery.

Screen Shot 2018-10-06 at 12.33.24 PM

 

Women are always working hard to take care of their family, friends and work. But they seldom have time to think of or take care of themselves. Too often they ignore some of their acidic symptomologies because they don’t think it’s a big deal and don’t take the time to get their breasts examined once or twice a year via non-radioactive thermography for breast physiology and ultrasound for breast anatomy.

Though warning signs do not always mean a cancerous condition, women and NOW men need to pay attention to the following acidic symptomologies when they are persistent and progressive. The following 20 cancerous symptomologies that effect women and NOW men’s breasts are those worth bringing to your doctor or health care professional’s attention.

Screen Shot 2018-10-06 at 12.33.37 PM.png

1. Breast Changes

If your nipple gets scaly or starts flaking, that could indicate Paget’s disease of the nipple, which is linked to an underlying cancerous condition in about 95% of cases. Any milky or bloody nipple discharge should also be checked out. In addition, dimpling of the skin over the breast, particularly if it looks like the skin on an orange is most often linked to an acidic inflammatory cancerous condition of the breast, a rare, usually aggressive cancerous condition characterized also by swollen, hot, red breasts. It is important to test the nipples using thermography to see in their is any significant temperature differences greater than 1 degree celsius.

2. Abnormal vaginal bleeding

Any bleeding, staining, little drops on your underwear, or big clots are abnormal and should be immediately evaluated by a health professional. Around menopause, abnormal bleeding is often tied to shifts in the endocrine system, though more serious problems could be the cause, which is why all abnormal vaginal bleeding should be checked.

3. Changes in vaginal discharge

Bloody, dark or smelly discharge is most likely a sign of out-fection. It’s best not to self-treat a discharge with over-the-counter acidic medications. A trans-vaginal ultrasound diagnositc examination is necessary to determine if the discharge is due to an out-infection or something more serious, such as a cancerous condition.

4. Unexplained Weight Gain or Loss

Weight loss by exercising and eating healthy alkaline foods and drinks should not be a concern. But if you suddenly lose more than 10 pounds without changing your diet or exercise habits, that could be caused by the body transforming body cells into blood cells, which is also know as body wasting due to congestion or damage to the intestinal villi where primary stem cells are made and then converted to blood and body cells.

5. A bloated belly

It’s common to feel bloated after eating or drinking an acidic constipating meal, especially during your menstrual cycle. But if you feel bloated and constantly full with no appetite for more than two weeks or after your period ends, you should have an abdominal thermography and ultrasound to see if there are any blockages.

6. Acute Fatigue

The American Cancer Society defines fatigue as “extreme tiredness that does not get better with rest.” So if you’re often fatigued, you are suffering from stage 1 acidosis and need to evaluate your lifestyle and diet. Leukemia, colon, or stomach cancer — which can cause blood loss, are what I refer to as stage 7 acidosis and may be the reason for your extreme fatigue. Fatigue is always a precursor to inflammation and inflammation is always a precursor to a cancerous condition. So fatigue is the body’s lack of life-force energy to remove its own acidic waste products that are building up in the connective and fatty tissues. This build-up of acidic waste from what you eat, what you drink and what you think is what causes gradual weight gain and fatigue and tiredness.

7. Change in the Appearance of a Mole

Keep an eye on any changes you notice on your skin all over your body. You can follow the ABCD method recommended by the Skin Cancer Foundation and the American Academy of Dermatology to help detect possible problems:

If the mole is A, asymmetrical; B, has uneven borders; C, has changed in color; or D, changed in diameter, then you are eliminating acidic waste products through the pores of the skin which can lead to a cancerous condition. It is important to open up the channels of elimination to remove toxins or dietary and/or metabolic acids out through urination and defection rather than through the pores of the skin. Removing waste products through the skin is always problematic and is the cause of all skin problems.

8. Swelling in legs, poor circulation or persistent pain in joints

 

 

Swelling in one leg can mean a blood clot. If it’s in both legs, it could be a sign of lymphatic circulation blockage which may lead to kidney or liver dis-ease. Chronic or constant acidic pain in joints could mean something more serious than arthritis, such as latent tissue acidosis or sometimes diagnosed as lupus or rheumatoid arthritis, which will require lymphatic drainage through massage, infrared sauna and colon hydrotherapy in order to improve circulation and then elimination via the bowels and kidneys. Remember that the lymphatic system is the vacum cleaner of acidic waste from the tissues and to function needs pleanty of water (up to 6 liters of alkaline water at a pH of 9.5) and exercise to pump acids out of the body via the pores of the skin or the urinary tract system.

9. Congestion or Constipation of the bowels

 

This is where health or ALL disease begins. A healthy core means a healthy body and especially healthy breasts. Breasts are primarily fatty tissues and a depository for acidic waste products that are NOT properly eliminated via the four channels of elimination – bowels. kidneys, lungs and skin. When the bowels are congested or constipated then toxins or acidic waste products from diet and metabolism seep into the blood and are then pushed out into the connective and fatty tissues, including the fatty breast tissues. Since acids are the cause of breast cancer, the focal point of breast cancer begins in the small and large bowels. Proper elimination of toxic acidic waste products is extremely important for a healthy body and healthy breasts. Ideally a woman or a man should be eliminating the bowels 6 tmes a day and at least 4 times a day to prevent ANY cancerous condition including breast cancer. Anything less than 4 bowel movements a day is a sign of constipation and a huge risk for breast cancer.

10. Big Breasts is a Big Risk for Breast Cancer

 

 

Why?

Because the body uses the fatty breast tissues as a depository for dietary and/or metabolic acids that are not properly eliminated through the four channels of elimination – bowels, kidney’s, lungs and skin. Thus, the bigger the breasts, the more potential acidic wastes can be deposited into the fatty breast tissues. This increases the risk for breast cancer in women who have big breasts. Today, 30 percent of all breast cancers diagnosis are men. Breast cancer is on the rise in men because they are growing breasts as a result of their lack of exercise, stress, hormone laced foods, GMO foods, coffee and acidic diets. So the smaller the breasts the lower the risk for breast cancer in both women and men.

11. Persistent cough and shortness of breath

Any persistent cough — one that lasts more than 2 or 3 weeks and is not due to an allergy or upper respiratory out-fection, or one that produces blood — needs to be checked via thermography, ultrasound and 3-D whole body functionality testing. What’s more, if you’re having continual or increased problems breathing, make an appointment to have these three tests done – full-body thermography, full-body ultra-sound and full-body 3-D functionality testing.

12. Change in Lymph Nodes

Swollen, firm lymph nodes are often caused by increase acidic which leads to poor blood and lymphatic circulation. Enlarged lymph nodes are the result of increased poor lymphatic circulation and the increase of toxic acidic waste products which have significantly built-up over time from an acidic lifestyle and diet. All cancerous conditions from lung, bowel, neck, and stomach always involves the lymphatic system and its inability to remove toxins from the connective tissues. It is important to improve blood and lymphatic circulation with an alkaline lifestyle and diet and especially increased hydration with alkaline water at a pH of at least 9.5. The increased alkaline hydration will help to reduce inflammation and decrease lymph node swelling.

13. Breast Skin itching

When the skin of the breasts are itichy this is the result of dietary and metabolic acids being eliminated out of the breast tissue through the pores of the skin. You can scratch and scratch or use steroidal creams but this will not solve the problem. The way to solve acids being pushed out through the pores of the skin is to increase circulation through super-hydration of alkaline water at a pH of 9.5.

14. Discoloration, spots or rash on the breast skin

When the body is throwing dietary and/or metabolic acids out through the pores of the breast skin this can cause irritation or stage 2 acidosis, white, red or brown spots on the breast as well as a rash.

15. Calcium deposits in the breast tissue

Calcium deposits can be seen with Ultrasound without harmful acidic radiation or stress and/or damage to the breast tissue via a mammogram. Calcium deposits are the chelation of metabolic and/or dietary acids that have not been properly eliminated through urination or defecation. The body will buffer these acids to protect the breast tissue from acidic breakdown. As acids built-up in the breast these acids spoil cells and begins the process of cellular degeneration or cancer. Calcium deposits on the breast show-up as white spots on Ultrasound.

16. Inflammatory ducts leads to Inflammatory ductal cell carcinoma

All inflammation is caused by dietary and/or metabolic acids which have not been properly eliminated through urination or defecation. When acids are NOT removed they spoil or ferment breast cells, even ductal cells which leads to inflammation and then to cancer or carcinoma. The inflammation of the breasts and ducts is seen via a breast thermography.

17. Breast lesions

Breast lesions or ulcerations are always the result of the body depositing dietary and/or metabolic acids into the fatty breast tissues when these toxic waste products are NOT being properly eliminated through urination, defecation, respiration or perspiration. These lesions or ulcerations are best seen by a breast Ultrasound.

18. Breast cysts

Breast cysts are the encapsulation of dietary and/or metabolic acids and are generally not considered cancer by current medical doctors. However cancer is NOT a cell but an acidic dietary and/or metabolic liquid which is cancer causing. Acids are poisons that posion body cells, including breast cells and are the cause of ALL cancerous conditions. The cyst is the body’s attempt to protect healthy breast tissue. Breast cysts are best identified with a breast Ultrasound.

19. Breast tumors

 

 

Breast tumors are the body’s defensive mechanism to stop the degeneration of breast cells. When breast cells have been spoiled by dietary and/or metabolic acids the body will create a protein called fibrin to form a tumor to encapsulate spoiled or rotten unhealthy cancerous cells. The formation of a tumor protects healthy breast cells from being spoiled by the unhealthy breast cells where one spoiled breast cell spoils another healthy cell, in a protective process I call the ‘domino effect.” Tumors are best seen using diagnostic ultrasound which can also see if the tumor is solid or if the tumor has blood supply. Tumors that are solid without blood supply are generally non-malignant. Tumors with blood supply are active tumors and are generally cancerous or malignant and are capable of expanding in size. The healthy process in breast healing is for the tumor to encapsulate the spoiled cancerous breast cells and cut off any blood supply resulting in a hard clot or tumor which will eventually become as hard as a rock. Eventually these rock hard tumors will stop their progressive ‘domino effect’ growth and will begin to shrink and then breakdown without radiation or chemical therapy.

20. Is There Cure for Breast Cancer?

The cure for breast cancer is found in its prevention NOT in its treatment. Healthy breasts are alkaline breasts. The human body is alkaline in its design although acidic in all of its functions. Breathing, thinking, eating, moving all produce acidic waste products if not eliminated will be deposited into the connective and fatty tissues causing irritation, then inflammation, then induration, then ulcerations, and finally degeneration or cancer. There is only one cause and one word that describes cancer – ACID!!!!!!!!!!!!!!! Prevent acid build-up in the connective and fatty tissues with an alkaline lifestyle and diet and you will prevent and/or reverse ANY cancerous condition, including breast cancer.

0-4

 

To learn more about Dr. Young’s self-care to a self-cure for breast cancer read The pH Miracle for Cancer and Reverse Cancer NOW! www.drrobertyoung.com, http://www.phmiracleretreat.com, http://www.phoreveryoung.com, http://www.ijuicenow.com, http://www.innerlightblue.com

To learn more about not-toxic, non-acidic and non-invasive diagnostic thermography and ultrasound go to: www.universalmedicalimaging.com

Screen Shot 2018-09-24 at 5.52.13 PM.png

Are YOU or a LOVED One Suffering from Psoriasis or Eczema?

Have YOU Tried an Alkaline lifestyle and Diet as outlined in Chapter 11 of The pH Miracle revised and updated book?

https://www.amazon.com/gp/product/0446556181/ref=dbs_a_def_rwt_bibl_vppi_i0

Danielle Cadell, from Omagh, Northern Ireland, (pictured above) was so self-conscious about her skin she started a blog to post photos of it in a bid to try to embrace it without shame. She had suffered with psoriasis since she was 15 years of age – and found that stress made it worse.

“It really knocks your confidence,” said the 29-year-old full time carer. “It started off mild but then covered me virtually from head to toe. It was so painful, my arm could have fallen off with all the scratching. “I tried methotrexate but as well as the side effects of nausea, I was worried about having to have tests for my liver function and I thought what is this doing to me? It wasn’t a long-term solution.”

Then Danielle heard about the pH alkaline lifestyle and diet.

“The results are fantastic. Nightshades – tomatoes and aubergines – and spicy food are triggers for me so I avoid them”.

“Stress causes flare ups so I now meditate and make sure I exercise and it’s worked wonders. I still have flare ups when I’ve not been following the alkaline diet a hundred per cent. I’m human and it’s easy to slip up but then I get back on it”.

“Finally I feel in control, after realizing that what I put into my body impacts the state of my skin.”

 

Glenda Metcalfe (pictured above) developed psoriasis eight years ago after getting strep throat. At first it wasn’t too bad, but then it became so severe her doctor put her on chemotherapy drug methotrexate.

“I had the plaques all over my body, including my scalp which is awful as it gives you dandruff” said the 49-year-old from West Sussex. “It gets you down, especially in the summer when you want to wear nice dresses. “I tried UV light therapy and that didn’t work for me. Steroid creams would calm things down but I’d get a flare-up as soon as I stopped using it. “I was on the methotrexate for three months. It didn’t have any effect and I was extremely sick, nauseous and couldn’t carry on with it.” After a bad flare-up last summer, Glenda went to on a pH alkaline retreat. “Within three weeks my skin had cleared after following the diet very strictly. “I notice now that it comes back if I go off it, dairy and sugar are the worst culprits for me, which for me is proof that this works. I would say my skin is 98 per cent cleared up when I follow the diet.”

 

Hanna had eczema as a child and at 15 developed psoriasis. By the age of 35 her skin problems were worse than ever, with plaques covering her eyelids, arms, legs, chest, tummy and scalp. She said she remembers feeling helpless when the doctor told her there is no cure.

“Not once was diet suggested as a potential factor,” she said.

“This is not about making somebody feel bad for what they’re eating, it’s about educating people to help them make better choices for their health and skin.”

Now she has clear and beautiful skin but following a pH alkaline lifestyle and diet.

If you’re ever feeling down about your skin … think of Charlie 💕 This gorgeous, inspiring little girl has battled psoriasis ever since she was a baby. Her ‘before’ pictures show just how tough topical steroid withdrawal is to go through. Her incredible family made the decision to stop medication in favor of healing Charlie through an alkaline pH diet. As an adult this is such a difficult decision to make … watching your little girl go through this I can’t even imagine. How awesome does Charlie’s skin look now?!

 

I know many of you feel disheartened if you don’t see change within days, but this is day 212 for Tiffani. The key is to make this enjoyable and a sustainable lifestyle rather than ‘a die it’ I call it the pH Miracle Lifestyle and Diet.

The hardest part of the pH alkaline lifestyle and diet is to start. Once you start the 12 week pH Miracle cleanse the rest is easy. Read and learn now how to improve the health of your skin – https://www.amazon.com/gp/product/0446556181/ref=dbs_a_def_rwt_bibl_vppi_i0

Pathological Blood Coagulation and the Mycotoxic Oxidative Stress Test (MOST)

0-5
Volume 2 Issue 6 – 2016
Pathological Blood Coagulation and the Mycotoxic Oxidative Stress Test (MOST)
Robert O Young*
Universal Medical Imaging Group, USA
Received: December 07, 2015 | Published: September 20, 2016
*Corresponding author: Robert O Young, Universal Medical Imaging Group, 12410 Burbank Blvd, Valley Village, California, 91607, USA, Tel: 760 751 8321; 818 987 6886; Email: ;
Citation: Young RO (2016) Pathological Blood Coagulation and the Mycotoxic Oxidative Stress Test (MOST). Int J Vaccines Vaccin 2(6): 00048. DOI: 10.15406/ijvv.2016.02.00048

Introduction and Historical Perspective

More than 150 years ago, British physician T. W. Jones asked the question, “Why does the blood circulating in the vessels not coagulate?” [1]. though a general answer to this question is now obvious, the biochemical mechanisms involved in how the blood coagulates (clots) are complex and varied, and all the intricacies have not yet been explained. A. Trousseau recognized that the blood of cancer patients is in a hyper-coagulable state in the process of coagulation, even while confined in the blood vessels [2].  The name given to this discovery is still in use today, as “Trousseau’s Syndrome” [2]. Early in his career, Rudolph Virchow, the Father of Pathology, was interested in thrombosis and embolism.  He speculated that intravascular blood could be altered so it would clot as a result of a stimulus too weak to clot normal blood [3]. In 1856 Virchow delivered a lecture setting forth this concept.

Although the concept of partial clotting within vessels reaches back to the beginnings of modern medicine, much of the discovery of its biochemical mechanisms-the activation of clotting factors-has been left to chance.  The admission of a patient to the hospital with an unceplained bleeding disorder challenged researchers to discover the cause of hemorrhaging.  Analysis of blood from normal persons helped in the study of the patient with the blood disorder. A new clotting factor was hereby discovered which was missing from the  patient’s blood.  For this reason, several clotting factors have been named after the individuals in which they were missing: e.g., Christmas factor (factor IX) [4], Hageman factor (factor XII) [4].

In this article, the causes of pathological (intravascular) clotting will be described, as will various methods of detecting this condition, especially a blood test I call the Mycotoxin Oxidative Stress Test (MOST).

The Mechanics of Blood Coagulation

 

Blood clotting is a highly detailed chemical-mechanism involving many distinct components.  The problem for the hematologist has been to understand it at the biochemical level.  Undoubtedly, efforts to fully understand blood clotting will continue for many more years.

Recalling Antione Bechamp’s [5] and Gunther Enderlein’s [6] research into the sub cellular living elements and combining this with what is known of colloidal flocculation [7], it is suggested that the clotting of blood begins with the end-linking (polymerizing) of the fundamental protein unit called by Be champ the microzyma [5].  A chain of these living units constitutes fibrinogen, which is still dispersed 9micro-hetergenous0 in the blood, and it may or may not be further processed.  If processing continues, it will be either by continued end-linking or by cross-linking.  End-linked fibrinogen is referred to here as fibrin monomer, which I have suggested is a repair protein also dispersed in the blood. Due to a number of blood clotting factors, the process may continue until the excess fibrin monomer and/or until fibrin becomes excessively end-linked.

Cross-linking the polymerized strands to form a three-dimensional network results in what is called the hard clot (fibrin – the major protein of clotting blood).  Factor XIII, which instigates the forming of these blood networks. Is always present but latent in the blood, and must be activated before the formation can occur.  Persons who are producing fibrin monomer or excessively linked fibrinogen are said to be in a hyper-coagulable state, while those having diminished ability to form clots are in a hypo-coagulated state.  It is the activation of the colloidal clotting factors which is so complex.  Blood clotting may occur through many pathways and be initiated by many different stimuli.  Regardless of initiation factors, the process is a sequence of events in which the activation of one factor triggers another, until, after a series of discrete steps, fibrin is formed.

When blood is clotted prematurely, and the factors involved are consumed (incorporated into) the body recognizes a deficiency of clotting agents and generates more.  Thus, people with a tendency to clot excessively will alternate between a hyper coagulable state and a hypo-coagulatable state.  When in the hypo coagulated state, such people hemorrhage until the deficient clotting factors are replaced [4].  When only fibrin monomer or excessively linked fibrinogen is formed (no cross-linking), it is quite subtle and may go undetected.  It may be detected by a change in blood viscosity (sedimentation rate), by the Mycotoxic Oxidative Stress Test (described later), or by other more subtle means.  If strands of fibrinogen are cross-linked, however, a suggicient amount of insoluble precipitate of fires may result, and these can be detected microscopically using a phase contrast and dark-field microscopy in prepared slides of fresh tissue or blood.  An excessive formation of fibrin leads to an impairment in circulation, and eventual organ failure usually results [8].

With this background, we are in a position to consider a standard medical term: disseminated intravascular coagultion (DIC) [7].  This term encompasses the hyper coagulable state, I refer to as pathological blood coagulation which consists of both insoluble and excess dispersed polymers of colloidal proteins.

Key Ingredients of Pathological Blood Coagulation

Before discussing DIC in more detail, it is necessary to introduce its fur important ingredients according to this view – mycotoxins, endotoxins, exotoxins, and tissue factor.  Any of these elements, or any combination of them, can play a major role in initiating unwanted DIC [7].  However, mycotoxins or the acids from yeast have been found to be the underlying element which instigates and intensifies the participation of the other three [6].  Each will now be described in turn and brought into the clotting picture (Monograph 1).

Monograph 1: Left, shows normal hyper-coagulated blood in a healthy blood clot sample and right, hypo coagulated blood in an unhealthy blood clot sample.

Mycotoxins and Metabolism by Fermentation

As discussed in the main text of my published book, Sick and Tired book [9]. Acidification of blood and body tissues and organs and the accompanying lack of oxygen lead to pathological metabolic fermentation, which is carried out primarily by yeast and mould.  Such pathological microorganisms, or their precursors, are inherent to the human body and to all higher organisms.  Their precursors according to Bechamp, the microzymas, carry on a nominal and homeostatic fermentation themselves. Under healthy conditions [5].  The primary function of yeast and mould is to decompose the body upon the death of the animal or human organism.  Their premature overgrowth indicates a biochemical environment akin to death.  During pathological metabolic fermentation, high concentrations of several acidic substances called mycotoxins are created.  They are highly damaging, always acidic, metabolic products.  If not immediately buffered by specific antioxidants, such as hydrogen peroxide and the hydroxyl free-radical, mycotoxins can seriously disrupt the physiology by disrupting normal metabolism and by penetrating blood and body cells and poisoning them.  As will be seen, they interact with many of the mechanisms for DIC in various pathological symptomologies.

In my published article called The Finger on the Magic of Life: Antoine Bechamp, 19th Century Genius (1816-1908), I discuss pleomorphism in some detail [9]. Understanding this phenomenon – the rapid evolution of microorganisms across traditional taxonomic lines is helpful in getting a complete picture of DIC.  Briefly stated, colloidal living microzymas evolve intracellularly into more complex forms (microorganisms), beginning with a healthy primitive stage comprising of repair proteins.  As the disease condition worsens, morbid intermediate forms (filterable bacteria or viruses, cell-wall deficient forms and full bacteria) develop from repair proteins, or directly from microzymas.  A third macro stage comprises the commonly recognized culminate microorganisms which are yeast, fungus to mould.  In terms of pleomorphism, all of these microorganisms represent a single family of variously functioning forms [5]. The culminate forms produce the lion’s share of acids, which are mycotoxins and the primary focus of my research [5,6,9]. For convenience, bacteria, yeast, fungus and mold that produce acidic metabolic wastes and protein cellular fragments called exotoins, endotoxins and mycotoxins will here be referred to collectively ash EMPO, or exotoxic, mycotoxic-producing microorganisms.

What follow is a shortened description or the description and origin of several exotoxins and mycotoxins, referred to collectively microzymian acidic toxins of MAT, which are involved in the processes leading to DIC.  The bio-effects or the pathology of cellular fermentation, of these toxic metabolites are known as mycotic illness, mycotoxicosis, or mycotoxic stress as seen in the MOST and described and published by Dr. Bolin in the 1940’s [10].

One such metabolic product is acetyl aldehyde, which is formed by cellular breakdown of food, especially carbohydrate and the birth of EMPO.  Acetyl aldehyde can also break down into a secondary substance known as ethyl alcohol.  Although acetyl aldehyde presents an immediate hazard to health and well-being, nature has provided a means of buffering of neutralizing this acidic by-product of cellular digestion and fermentation almost as soon as it is created [11]. The controls of acetyl aldehyde (and ethyl alcohol) are the sulfur amino acids, cysteine, taurine, methionine and the peptide glutathione which is found in red blood cells and almost all cells utilizing oxygen [12].  In an attempt to buffer or neutralize MAT, the body will also bind or chelate both fats and minerals to them [12].

Another member of the MAT family is uric acid, which is formed by the digestion of protein and the creation of EMPO [13].  Uric acid can also break down into secondary substance, one of which is alloxan [14]. This has been shown to damage the insulin-producing pancreatic beta cells leading to diabetes [Monograph 1 & 2].

A shortage of alkalizing nutrients or an excess of MAT initi­ates an immune response in which a special class of free radicals which I call microzymian oxidative buffering species (MOBS) are released [15]. These oxygen metabolites carry unpaired electrons and are intended to disrupt bacteria, yeast, fungus and mould, and buffer exotoxins, endotoxins, and mycotoxins. Current medical savants believe that they can disrupt just about any­thing they contact, including healthy cells and tissue: this is not accurate. The fact is that MOBS carriers a nega­tive surface-charge and repel healthy cells, which also have a negative surface-charge [16]. It is the positively surface-charged bacteria, yeast/fungus, mould, exotoxins, endotoxins, and myco­toxins that MOBS bind too [17].  This aspect gives some insight into autoimmune phenomena, which are not, as is often maintained, the result of an overburdened immune system. They result either as a side-effect of the immune system’s attempt to remove foreign or toxic ele­ments, or as a direct attempt by the immune system to remove cells or tissue rendered useless or disturbing to the body by MAT.

Monograph 2: An Anxiety Profile showing a ‘snowstorm’ of 2 to 10 micron protein polymerizations starting from the center of the clot and moving out towards the edge.

In every degenerative symptomatology I have studied, I have found excessive MAT and MOBS (Tables 1-3). Some of these degenerative symptoms and their underlying disease conditions, including cancer are described in my recently published paper on a deficiency on alkaline nutrition and cancer [18]. But the fact that myco­toxins cause harm to humans and other animals is purely a secondary effect, since, as noted, the prima­ry function of the microorganism is not to cause illness. We know from the fossil record that pleomorphic microforms existed long before animals [19]. In fact, humans and animals developed in terms of micro­organisms [20]. The reverse, however, is not true. Since micro­organisms appeared first in the developmental sequence, they are not physiologically aware of humans and animals. There is much evidence that human and animal physiologies are highly aware of, and respond to MAT – these acidic compounds signaling the presence of bacteria, yeast, fungi and/or mould or EMPO [21].

Carbohydrate, Proteins, and Fats From Diet, Body Cells or Reserves

As cells breakdown or ferment they give birth to bacteria, yeast, fungus and mold [EMPO] and their associated metabolic acidic waste [MAT]

Exotoxins, Endotoxins, and Mycotoxins [MAT]

Acetyl Aldehyde, Ethyl Alcohol, Uric Acid, Alloxan, Lactic Acid are examples of MAT

MAT Ferments Other Body Cells and their Extracellular Membranes and Proteins

MAT Modifies Glycoprotein

Binds to liver Galactosidase

Creating an Increase in Cell and Protein Fermentation and Degeneration and Increased Amounts of Exotoxins, Endotoxins and Mycotoxins [MAT]

Table 1: Expression of Sialic Acid/Galactose [MAT] from Cell and Protein Degeneration (From All Serum Proteins, RBC/WBC and Other Cell Surfaces.

Pancreatic Insulin producing Beta-Cells with no or
minimal Surface Sialic Acid [MAT]A Physical and/or Emotional Disturbance Occurs from Lifestyle and/or Diet

Normal regulation of Insulin Production

A Physical and/or Emotional Disturbance Occurs from Lifestyle and/or Dietary choicesdd

Leads to cellular fermentation and degeneration and the birth of EMPO

This lead to increased abnormal amounts of MAT that the immune system, the alkaline buffering system and the elimination organs has to deal with

Fermenting and degenerating Insulin Producing Beta Cells

Giving Rise to Surface Cell Sialic Acid [MAT}

Increased Amounts of Sialic Acid Activates the Immune Response [MOBS] and Sialidase [AB]

Leads to Lowered or No Insulin Production

Symptoms of Type I, Type II or Type III Expressed

The insulin producing beta cells of the Islets of Langerhans express silica acid on their surface as a break
down metabolite. I have suggested that when insulin producing beta cells are physically disturbed by MAT
they begin to disorganize and express sialic acid on the surface of the cell. This indicates the death of the cell
and insulin production will stop.

Table 2: Expression of Sialic Acid [MAT] From the Fermentation of Degeneration of Insulin Producing Pancreatic Beta-Cells in Type I, Type II and Type III Diabetes.

 

A Physical and/or Emotional Disturbance Occurs from Lifestyle and/or Dietary choices

Leads to cellular fermentation and degeneration and the birth of EMPO

This lead to increased abnormal amounts of MAT that activates the immune system to chelate the MAT.

Increased amounts of MAT will cause endothelial breakdown and the expression of Sialic acid.

Increased Amounts of Sialic Acid and damage to the endothelial will cause a reduction in the negative
surface-charge leading to the release of Glycoproteins.

The release of Glycoproteins will cause the activation of Factor XII and the blood clotting cascade.

This cause the creation and formation of fibrin monomers and the increase of Platelet Deposition out of the
red blood cells for clotting purposes

The immune system will activate and MOBS will be released as well as sodium bicarbonate, calcium, lipids
and other alkaline buffers to reduce metabolic acidity.

The build-up of fibrin monomers in the clotting cascade will lead to fibrin nets and clots causing an increase
in blood pressure and the risk of blockages potentially causing a Stroke or Heart Attack.

Table 3: High Blood Pressure, Atherosclerosis, Heart Attacks, Strokes, and Congestive Heart Failure.

 

Endotoxins

Also involved in the process leading to DIC are endotoxins, substances endogenous to symptogenic (i.e., “pathogenic” in orthodox terms) bacteria. Endotoxins are a family of related substances having certain common characteristics, but differing from one bacterial form (or strain) to another. Endotoxins are lipopolysaccharides (LPS). LPS form a widely diversified group because of [1] the number of long- chain fatty acids composing lipids; [2] the number of individual sugars as well as their modes of linkage to one another; [3] the branching of sugar chains; and [4] the number of possible arrangements of these units. Endotoxins also contain proteins, further com­pounding the structural diversity [22].

One theory on endotoxin states that its purpose is to act as a semi-permeable membrane for the bac­terium, limiting and regulating substances entering the organism [22]. Endotoxin resides solely on or near the interior surface of the cell membrane and is shed into the surrounding medium only upon the death of the bacterium. Thus, as these microforms die off, or are lysed by bodily activity, endotoxin is released. (This fact may well be an explanation for the Herxheimer reaction, in which a patient becomes worse following the administration of toxic drugs or other forms of treatment that drastically alter the associated organ­ism [22].  Another endotoxin theory states that LPS are a constituent of the membrane, and as the organism grows, endotoxin fragments are repeatedly sloughed off into the medium. This phenomenon has been observed in the digestive tract [22]. Since bacterial translocation into the blood is not only possible but common where epithelial hyperpermeability exists, one can assume that the process will continue there. Both theories may be correct if we think of the first one as true of “adult” forms, and the second as true of newly developed and expanding ones.

Basic to the structure of an endotoxin is the lipid common to all forms, designated lipid A, to which is attached a “core” polysaccharide, identical for large groups of bacteria. To the core polysaccharide is attached the O-antigen, consisting of various lengths of polysaccharide chains which are chemically unique for each type of organism and LPS. These chains pro­vide endotoxin specificity [23]. Experiments conducted over many years indicate that most, if not all, of the toxic effects of an endotoxin may be attributed to the lipid portion, and it is sometimes used per se in experiments rather than the entire molecule [24]. An important additional feature of lipid A is its phos­phate content. Each phosphate group carries a nega­tive charge, and since lipid A is a rather large mole­cule, it provides, essentially, a negatively charged sur­face. The importance of this will be seen shortly.

Exotoxins

These are the metabolic excretions of bacteria. While endotoxin’s ongoing effect is, in a manner of speaking, in the background, exotoxins, like myco­toxins, present a double-edged sword. Not only do they initiate DIC, but they produce, or influence the body to produce, the various and numerous infec­tious symptomatologies, such as typhoid fever, diph­theria, etc. (See “Vaccination Reconsidered” in Section 4 of the Appendix of Sick and Tired for details on the action of diphtheria toxin) [6]. By comparison, mycotoxins not only initiate DIC, but there is much evidence to sug­gest that they produce, or influence the body to pro­duce, degenerative symptomatologies, such as arthri­tis, diabetes, etc., and cancer and AIDS as well.

Tissue factor

Crucial to the understanding of DIC is recogni­tion of the role of tissue factor (TF), formerly known as thromboplastin. This transmembrane lipoprotein exists on the surface of platelets, vas­cular endothelial cells, leukocytes, monocytes, and most cells producing EMPO [24]. It plays a major role in several biochemical mechanisms leading to DIC.

TF is the primary cell-bound initiator of the blood coagulation cascade. Its gene is activated in wound healing and other conditions. By itself it is capable of initiating clotting, but also becomes active when complexed with factor VII or activated factor VII (Vila) [25]. TF has been described as the receptor for factor VII because of the close association between the two proteins and because it causes a shape change (conformational) in factor VII, allowing it to attain activity. Both factor Vila and the TF/VII com­plex activate factors IX and X, which initiate the clotting cascade and the formation of thrombin [4].

Development of Disseminated

Intravascular coagulation (DIC)

DIC induced by MAT and tissue factor: An infusion of toxins into the blood has a direct effect on TF gene expression in leukocytes. Contact of MAT, endotoxins (lipid A), or exotoxins with leukocytes, activates proteins that bind to DNA nucleotide sequences, thereby activating the TF gene [4] (Tables 4-6).

A Physical and/or Emotional Disturbance Occurs from Lifestyle and/or Dietary choices

Leads to cellular fermentation and degeneration and the birth of EMPO

This lead to increased abnormal amounts of MAT that activates the Tumor Necrosis Factor (TNF).

Increased amounts of TNF activates the Tissue Factor Gene (TF)

Increased Amounts of TF causes the release of Thromboplastin.

The release of Thromboplastin activates the release of clotting Factors VII (VIIa) and trace amounts of
Factor Xa into the blood.

This activates the release of Factors IX and X to IXa and the increase of Factor Xa.

The activation of the blood clotting cascade leads to Disseminated Intravascular coagulation and the clotting or
thickening of the blood inside the blood vessels.

The DIC or hyper-coagulation will mask the fermentation of healthy cells to unhealthy cells or cancerous cells.

As the unhealthy cells or cancerous cells increase the body will go into preservation mode and begin forming
fibrin nets to encapsulated these unhealthy cells to protect healthy body cells.

As body and blood cells breakdown from MAT this causes an increase of MAT and EMPO leading to systemic
latent tissue acidosis and a potential metastatic cancerous condition.

Table 4: Disseminated Intravascular Coagulation Resulting from Intracellular Disorganization or Fermentation which Gives Rise to Mat and Empo.

 

A Physical and/or Emotional Disturbance Occurs from Lifestyle and/or Dietary choices

Leads to cellular fermentation and degeneration and the birth of EMPO

This lead to increased abnormal amounts of MAT that activates the Tumor Necrosis Factor (TNF).

Increased amounts of TNF activates the Tissue Factor Gene (TF)

Increased Amounts of TF causes the release of Thromboplastin.

The release of Thromboplastin activates the release of clotting Factors VII and Factor Xa in the blood.

This activates the release of Factors IX and X to IXa and the increase of Factor Xa.

The activated blood clotting cascade leads to Disseminated Intravascular coagulation and the clotting or
thickening of the blood inside the blood vessels.

The DIC or hyper-coagulation will mask the fermentation of healthy cells to unhealthy cells or cancerous
cells.

As the unhealthy cells or cancerous cells increase the body will go into preservation mode and begin forming fibrin
nets to encapsulated the unhealthy cells.

This leads to tumor formation of the unhealthy or cancerous cells.

As the body and blood cells breakdown this causes an increase of MAT and EMPO leading to an increased
risk of systemic metastatic cancer.

Table 5: Disseminated Intravascular Coagulation Resulting in Cellular Disorganization or Fermentation and the Increase of Mat and Empo.

A Physical and/or Emotional Disturbance Occurs from Lifestyle and/or Dietary choices

Leads to cellular fermentation and degeneration and the birth of EMPO

This lead to increased abnormal amounts of MAT that activates the Tumor Necrosis Factor (TNF).

Increased amounts of TNF activates the Tissue Factor Gene (TF)

Shedded vesicles with TF coming from disorganizing fermenting body cells activates the release of clotting
Factors VII (VIIa) and small amounts of Factor Xa in the blood.

This activates the release of Factors IX and X to IXa and increased amounts of Factor Xa.

The activated blood clotting cascade leads to Disseminated Intravascular coagulation and the clotting or
thickening of the blood inside the blood vessels.

The DIC or hyper-coagulation will mask the fermentation of healthy cells to unhealthy cells or cancerous cells.

As the unhealthy cells or cancerous cells increase the body will go into preservation mode and begin forming
fibrin nets to encapsulate the unhealthy cells.

As body and blood cells breakdown this causes an increase of MAT and EMPO leading to systemic
metastasis.

Table 6: Endotheial Cell Conversion from an Antithrombotic State to a Procoagulant State Cellular Disorganizing Pathway.

Endothelial cells damaged in culture by exotoxins, endotoxins, or mycotoxins attract polymorphonuclear leukocytes (PMNs), which adhere to the damaged cells. Once the leukocytes are bound, they can still have their TF gene activated if it hasn’t yet occurred, and they may release MOBS in response to toxins and to organisms of disease, possibly creating further dis­turbances. (Cellular disorganization then releases acti­vating proteins into the blood, which is discussed in more detail later.) Research shows that exotoxic and mycotoxic stress resulting in bound PMNs can be blocked by “antioxidants” [26]. These might better be called anti-exotoxins or antimycotoxins. Both observa­tion and study have led the author to conclude that cellular disorganization is initiated and primarily caused by fermentation pathology, not, as is the cur­rent belief, by the MOBS, or free radicals, generated to destroy toxins and microorganisms. MOBS or free radicals, because of their negative charge, are released to chelate or bind EMPO and MAT. It is suggested by current savants that free radical tissue damage is the secondary, “shotgun” effect of intense immune response to EMPO toxification and MAT-damaged cells. This could not be the case since healthy cells or their membranes carry a negative charge and would resist any electromagnetic attraction because of simi­lar charge. The concentration and instability of MAT generated in a compromised terrain, as opposed to the fleeting existence of free radicals, especially exoge­nous ones, also lead to this conclusion.

Endothelial cells grown in culture can be induced to express tissue factor. In one experiment, no procoagulant activity could be detected in the absence of toxins. However, the addition of mycotoxins from Aspergillus niger or Micrococcus neoformas (Mucor racemosus Fresen)resulted in procoagulant activity which reached a maximum in four to six hours and was dose-dependent. The same experiment was applied using E. coli and Salmonella enteritidis endo­toxin with a similar result [27]. A single intravenous injection of a mycotoxin from Aspergillus niger into experimental animals resulted in circulating endothelial cells within five minutes. In other exper­iments with the mycotoxin, detachment of endothe­lial cells from the basement membrane was noted [28] (Table 7).

Table 7: Mechanism of Disseminated Intravascular Coagulation Generated by Mat.

Removal of endothelial cells has dire conse­quences from two standpoints: First, the surface of these cells is covered with a specific prostaglandin (PGI2) known as prostacyclin. If blood contacts a surface not covered with PGI2, it will clot. For example, surfaces devoid of this prostaglandin are formed whenever a vessel is cut or punctured. An abrasion or other injury may also expose a surface on which PGI2 is lacking. The removal of endothelial cells by exotoxins or mycotoxins creates a surface devoid of PGI2, leading to blood clotting (Table 8). Secondly, disorganization of endothelial cells cre­ates increased levels of EMPO and MAT which are attracted to an exposed surface (basement mem­brane) which expresses a negative charge. This also leads to clotting.

Table 8: Endothelial Cell Conversionfrom an Antithrombotic State (Normal Pathway).

DIC induced by electrostatic attraction: It was discovered in 1964 that blood will clot sim­ply from contacting a negatively charged surface [29]. Previously it was believed that the clotting process comprised a cascade of enzyme activity in which one activated the next, etc. The discovery that blood could be clotted simply by contacting a negatively charged surface ruled out the purely enzyme hypoth­esis. Only some of the known clotting factors have been shown to be enzymes [29]. As a result of this sur­prising discovery, detailed research was conducted in an attempt to describe the process. In some experi­ments, the negatively charged surfaces of selected, finely divided, inorganic crystals, including aluminium oxide, barium sulphate, jeweler’s rouge, quartz, and titanium oxide, were considered [4].

The clotting factor eventually shown to be activat­ed when whole blood contacted negatively charged surfaces was factor XII, also known as the Hageman factor. This is a positively charged protein migrating in an electric field (electrophoresis) toward the anode [4]. It is believed that factor XII is normally in the shape of a hairpin which binds to the negatively charged sur­face at the bend. Electrostatic attraction forces the two arms to lie flat on the surface, thereby exposing the inner faces and activating the molecule.

It was discovered that if the negatively charged particles were smaller than the clotting factor itself, activation was minimal. Or, if the concentration of clotting factor was too great, there was little or no activation [30]. Both of these observations indicated that the process was one of electrostatic attraction between the negatively charged surface and the clot­ting factor, which is a “basic” protein, that is, posi­tively charged [22,23].

Activation of factor XII allows the activation of factor XI, which then activates factor IX. Thus, the blood clotting cascade continues to the formation of fibrin in the normal manner [31]. However, due to a series of activations begun by contact of factor XII with a negatively charged surface, trace amounts of factor Xa also show up in the blood. Factor VII is activated to Vila by factor Xa. Factor Vila then acti­vates factors IX and X, leading to the formation of thrombin. Factor Xa, with co-factor Va, continues the clotting cascade until fibrinogen is activated, leading to fibrin formation [4] (Table 5).

As discussed earlier in terms of prostacyclin, beneath endothelial cells is another surface—the basement membrane. Called the extracellular matrix, it is a thin, continuous net of specialized tis­sue between endothelial cells and the underlying connective tissue. It has four or more main con­stituents, including proteoglycans (protein/polysac- charide) [32]. The removal of endothelial cells by’ MAT exposes this membrane, which is negatively charged by virtue of its sulfonated polysaccharides in the pro­teoglycans. This brings a reduced negatively charged surface into direct contact with the blood, which activates factor XII and the clotting cascade [4]. The positively charged toxic components of MAT also activate factor XII, as do disturbed disorganized cells, yeast/fungus cells, mouldy cells, and the phos­phate groups in the lipid A component of endotoxin (Tables 2-5).

To summarize this section, exotoxic and mycotoxic stress resulting from overgrowth of bacteria, yeast/fungus, and then mold, has multiple actions, all leading to disseminated intravascular coagulation: MAT activation of tissue factor gene in leukocytes; subsequent activation of factors VII, IX, and X, resulting in the blood clotting cascade. MAT activation of tissue factor gene in endothelial cells, again leading to the clotting cascade.

MAT damage to endothelial cells, resulting in neu­trophil attraction, with TF gene activation and generation of MOBS, which, in turn, neutralize MAT, protecting healthy endothelial cells or the basement membrane and supporting the janitorial services of the leukocytes.

Removal of negatively charged endothelial cells by positively charged exotoxins, endotoxins, and mycotoxins, creating a surface devoid of PGI2, also exposes the negatively charged basement membrane, leading to the activation of factor XII and initiation of the clotting cascade. Positively charged components of EMPO, exotoxins and mycotoxins, and several other elements, including the lipid A component of bacterial endotoxin, also activate factor XII and the clotting cascade.

Endothelial cells as antithromboticsorprocoagulants: Normal, resting (unstimulated) endothelial cells show antithrombotic activity in several ways: [1] by the inhibition of prostacyclin (platelet adhesion and aggregation) [2]; the inhibition of thrombin genera­tion; and [3] the activation of the fibrinolytic system, leading to clot lysis [33]. We will take a brief look at the thrombin aspect.

On the surface of endothelial cells is a protein called thrombomodulin, which acts as a receptor for thrombin. When bound to thrombomodulin, throm­bin can activate protein C. Activated protein C then catalyzes the proteolytic cleavage of factors Va and Vila, thereby destroying their participation in blood clotting. Thus thrombin, which normally activates fib­rinogen, plays an opposite role in this case and inhibits the clotting process [33,34] (Table 8).

On the other side of the coin, the endothelial cell becomes a procoagulant agent when acted on by cer­tain lymphokines, such as interleukin-1. Not only can interleukin-1 induce TF gene expression, but it also suppresses transcription of the thrombomodulin gene in endothelial cells. As in other situations, the lymphokine-activated endothelial cell expresses TF on its surface as a result of TF gene activation. This leads to the production of thrombin and the trigger­ing of the blood clotting cascade [35]. (Table 5) Many lymphokines also stimulate adhesion of leuko­cytes to endothelial cells damaged by MAT, resulting in recycling of the cells by MOBS, as described later.

DIC induced by intracellular fermentation by bacteria, yeast/fungus and/or mould: Any cell which has gone from an oxidative to a fer­mentative state can biochemically cause macrophage production of the lymphokine tumor necrosis factor (TNF). This protein has been shown to activate the gene for TF in fermenting cells, which are so behaved due to morbid evolution of bacteria, yeast/fungus, and then mould [36,37]. In the author’s view, a cell having been switched entirely to fermentation metabolism as a result of a physical or emotional disturbance of that cell, is what constitutes cancer (Tables 5 & 9). (One might argue that this definition does not fit all “forms” of cancer, such as leukemia, for example. This is because leukemia is not cancer, but an immune response to the rise in EMPO and MAT in the body, and a relatively easy compensation to correct.)

Table 9: Positive Charge of Cancerous Cells and Tumors and the Formation of Fibrin Nets and Trees in Response to Mat.

The surface of many disorganizing or fermented cells (cancer cells) is characterized by small projec­tions in the plasma membrane which pinch off, becoming free vesicles containing toxins as well as TF complexes with factor VII. These vesicles can aggre­gate and/or lodge anywhere, ultimately releasing their contents. Also, the presence of excessive amounts of TF/factor VII complexes on the surface of fermented cells allows the formation of a fibrin net around the cell and around the entire mass of cells (tumor). This seems to be an attempt by the body to encapsulate and contain the mass. However, fermented cells do escape from the primary fibrin net, perhaps due to some electromagnetic effect, and become free-float­ing in the circulation. They may thus lodge elsewhere and instigate the fermentation of other cells by fungal penetration or by poisoning them and provoking a morbid evolution of their inherent microzymas.

Because of the surrounding fibrin net, these mobi­lized fermenting cells are protected from collection by the immune system while in transit [38] (Table 4). The blockage or dissolution of fibrin net forma­tion by an anticoagulant such as heparin allows freed, fermenting (metastasizing) cells to be dismantled by natural killer cells and other immune cells (Tables 5 & 9).

DIC induced by MAT/EMPO and immune system response (Release of MOBS): Unsaturated fatty acids are highly susceptible to EMPO as well as MAT. Linoleic acid, a long-chain fatty acid present in white cells, has 18 carbons and 2 unsaturations. Subjected to MAT, linoleic acid binds the exotoxin, endotoxin, or mycotoxin, there­by forming an epoxide at the first unsaturation [39]. Research has revealed that this compound, named leukotoxin, is highly disturbing to other cells. It caus­es platelet lysis, thereby releasing TF and initiating DIC [40] (Table 10). The fact that MAT result in fermented fats lends further credence to the sugges­tion that the initial and primary degenerative damage to structures and substances in the body is caused by exotoxins and/or mycotoxins, and that damage by MOBS, or by other free radicals, is not possible.

Table 10: Disseminated Intravascular Coagulation Resulting from Phagocytic Oxidative Burst.

Another mechanism leading to DIC is the release of a special glycoprotein, sialic acid, from the terminal ends of cell-membrane polysaccharides, where it is always found. Polysaccharides play a highly significant role in biochemical processes, with both enzymes and membrane receptors recognizing various groupings of specific sugars linked in highly specific ways.

Immediately preceding the release of sialic acid in the polysaccharide chain is the sugar galactose. The sialic acid/galactose arrangement is utilized as a biolog­ical indicator of cellular and molecular aging. As cells age, sialic acid is naturally expressed from the terminal ends of polysaccharides, thereby exposing galactose. A membrane-bound enzyme from the liver, galactose oxi­dase, recognizes galactose and eventually disorganizes it, disrupting cell function integrity and hastening demise. Aged red blood cells, which have expressed a significant amount of sialic acid, are removed from the blood by this process. (I theorize that the biological ter­rain may be at work in normal cell aging. That is, the rate at which sialic acid is expressed is determined by the levels of corrosive acids in the system and the body’s ability to remove them, although there are no doubt intracellular factors at work as well.)

I suggest from my years of clinical research that cellular breakdown is compounded by the fermentation of the galactose by the microzyma. This is a process that begins from within and not necessarily from without. Not only does this action create more sialic acid, it creates other toxic waste products such as acetic aldehyde, alcohol, uric acid, oxalic acid, etc. The increase in cellular disturbances and fermenta­tion of the galactose creates biochemical signals for more galactose oxidase. This leads to greater cellular disorganization and developmental morbidity, espe­cially in the red blood cells, and a rise in the level of detrital serum proteins, which encourages clotting. From this perspective, diabetes, arthritis, atheroscle­rosis and other symptomatologies become more clearly “degenerative” (Tables 2-5 & 9).

Fibrinogen is a rather elaborate protein having the structure of three beads on a string. Expressed on the end beads is sialic acid, which indicates the beginning of disorganization of the fibrinogen and a declining negative charge to the positive. Prior to the declining charge and the expression of sialic acid on the end beads, fibrinogen, which is negatively charged, will not polymerize the healthy blood due to mutual repulsion. However, fibrinogen will poly­merize to damaged cells, EMPO, MAT and other positively charged areas of the body for repair pur­poses. Thus, as more and more sialic acid is expressed, there will be a significant reduction in the charge of the fibrinogen, acting as the primary requirement for the polymerization of fibrinogen (hypercoagulable state). The resulting polymer, fib­rin monomer, is the protein chain used in the repair of cells and clotting of blood [41]. End-linking will take place after the release of sialic acid (positive charge) by whatever means.

With this background, it is interesting to note that blood taken from persons suffering from anxiety is expressing sialic acid from fibrinogen, and is halfway toward clotting. Hormones released during anxiety states are easily fermented, giving more momentum to MAT and thereby resulting in this important change in fibrinogen. It leads to a clotting pattern characteristic of anxiety stress, and is readily identi­fied in the M/OST. As can be seen in this picture, the pattern is a “snowstorm” of protein polymeriza­tions measuring from 2 to 10 microns (Monograph 2).

As mentioned earlier, despite the attempt by the body to neutralize EMPO and MAT, an excess will initiate the release of MOBS by immune cells. A major MOBS are superoxide, designated chemically as O 2. It may exist alone or be attached to another ele­ment, such as potassium (KO’2) or sulfur (SO). Again, however, nature has provided a means of pro­tecting healthy cells-their negative charge [1]. Another protection against superoxide is the enzyme superox­ide dismutase (SOD), also found in all healthy cells.

A second member of the MOBS family is hydro­gen peroxide (H202). This molecule is very unstable and tends to react rapidly with other biological mol­ecules, damaging them. The release of hydrogen per­oxide in the body is a response to the overgrowth of decomposition organisms in a declining pH (com­promised biological terrain). The control for healthy cells against hydrogen peroxide is their negative charge and the protective enzyme catalyse, one of the most efficient enzymes known.

When leukocytes and other white blood cells are stimulated by the presence of bacteria, yeast/fungus and mould, they treat these organisms as foreign par­ticles to be eliminated. During and prior to phagocy­tosis, the foregoing oxidative cytotoxins, along with the hydroxyl radical (OH’), are generated and released specifically for neutralizing microforms or harmful substances. This release is referred to as an “oxidative burst.” As a result of fermentation and the production of exotoxins and mycotoxins that fer­ment galactose from cells, the immune system is activated. An oxidative burst is released to neutralize the morbid microforms and mycotoxicity [42]. Like other biological processes faced with constantly alarming situations, the continued release of MOBS can get out of control. This may damage endothelial cells, the basement membrane, or other body ele­ments, and this activates fibrinogen to fibrin monomer (repair protein), leading to DIC (see Table 11). Interestingly, the white blood cells capable of neutralizing MAT through MOBS production are the same ones capable of phagocytosis, the process by which foreign matter, waste products and microor­ganisms are collected and dumped in the liver [43].

Table 11: Activation of Sialidase and Microzymian Oxidative Buffering Species (MOBS) by Empo and Mat.

To summarize this section, morbid microforms and their acids create DIC by a number of pathways

Leukotoxin (linoleic acid bound to mycotoxin) is highly toxic to cells. It causes platelet lysis, there­by releasing TF and initiating DIC. The expression or release of sialic acid residues from healthy cells that have been disturbed allows for the fermentation of galactose, creating exotox­ins and mycotoxins, biochemically activating galactose oxidase, which further disturbs and dis­organizes healthy cells. This cycle loads the blood with debris.

EMPO and MAT disturb fibrinogen, which releas­es sialic acid and reduces the charge, allowing it to polymerize into fibrin monomer and fibrin nets. The presence of exotoxins, endotoxins, and myco­toxins and their poisoning of cells activate the immune system. White blood cells generate MOBS (e.g., superoxide [0’2] or hydrogen perox­ide [H202]). These substances bind to and neu­tralize EMPO and MAT. MOBS are repelled by healthy endothelial cells and the basement mem­brane because of their negative charge. Cellular disturbances and disorganization stimulate the generation of fibrin monomer for repair purposes, leading to DIC.

Detection of Disseminated Intravascular Coagulation

The sonodot analyzer

The Sonoclot Coagulation Analyzer provides a reaction-rate record of fibrin and clot formation with platelet interaction. An axially vibrating probe is immersed to a controlled depth in a 0.4 ml sample of blood. The viscous drag imposed upon the probe by the fluid is sensed by the transducer. The electronic circuitry quantifies the drag as a change in electrical output. The signal is transmitted to a chart recorder which provides a representation of the entire clot for­mation, clot contraction and clot lysis processes. The analyzer is extremely sensitive to minute changes in visco-elasticity and records fibrin formation at a very early stage. The Sonoclot has been evaluated scientif­ically and shown to provide an accurate measurement of the clotting process [44,45].

One application of the Analyzer has been the development of a test to distinguish non-advanced breast cancer from tumors that are benign. The ratio­nale for the test is the hypercoagulable state seen in cancer patients (Trousseau’s Syndrome), resulting from the generation of TF by leukocytes (mono­cytes) [46]. (Table 4)

Fibrin Degradation

Products and fibrin monomer

DIC can be seen as a two-step process. First, fib­rinogen, which is always present in the blood, is acti­vated by any of several mechanisms. This activation leads to an automatic polymerization (chain forma­tion) resulting in fibrin monomer. This is not apparent in a microscope unless the blood is allowed to clot, as in the MOST [47,48]. The second step is the precipitation or deposition of fibrin (hard clot) by several other mechanisms. One of these is the formation of cross­ links through the action of factor XIII. Another such mechanism may be poor circulation in an organ already blocked by deposited fibrin. The deposition of precipitated fibrin may be detected microscopically in tissue sections and diagnosed as DIC [49].

Because fibrin monomer is not readily detected, a chemical test for it is of immense value in diagnosing DIC. Research has indicated that its detection may be very useful in the early diagnosis of DIC and MAT [50] There are three fundamental physiologic areas related to blood clotting:

  1. The prevention of blood clotting,
  2. The clotting of blood,
  3. The removal of clotted blood once it has formed.

Enzymes are present that are capable of removing (lysing) clotted blood, one of which is plasmin. Another enzyme, plasminogen, is always present in the blood, but is inactive as a proteolytic agent. Plasminogen acti­vator converts plasminogen to plasmin, which can degrade deposited fibrin. This process is not specific for fibrin, however, and other proteins may be affected. When fibrin is degraded (fibrinolysis), fibrin monomer, as well as several other products, are formed. Commercial kits are available for the analysis of fibrin degradation. This test is an indirect measure of the pres­ence of DIC and MAT [51].

Other tests include

Protamine Sulfate: Protamine sulfate is a heparin binder sometimes used in surgery for excessive bleed­ing. The test, which indicates fibrin strands and fibrin degradation products, is conducted in a test tube, with fibrin monomer and fibrin forming early and polymer­ization of fibrin degradation products occurring later [52].

Ethanol Gelation: A white precipitate is formed by the addition of ethanol to a solution in a test tube containing fibrin monomer as a degradation product of fibrin, indicating DIC and MAT [53].

The Mycotoxic/Oxidative Stress Test (MOST): Up to now, blood chemistries have been the prima­ry mode of diagnosis or analysis for the presence of pathology. In the view presented here, the bright-field microscope is used to easily and inexpensively reveal a disease state as reflected by changes in certain aspects of blood composition and clotting ability. DIC is char­acterized by the abnormal presence in the blood of fib­rin monomer. When allowed to clot, blood containing such an abnormal artifact will exhibit distortions of normal patterns. The presence in the blood of soluble fragments of the extracellular matrix and soluble fibronectin, as well as other factors, will also create abnormal blood clotting patterns as described below (Monograph 3).

Monograph 3: An abnormal clot with striking ‘clear’ or white areas or protein polymerization as seen in the hyper coagulated blood of a patient with lower bowel imbalances.

A small amount of blood from a fingertip is con­tacted with a microscope slide. A series of drops is allowed to dry and clot in a normal manner. Under the compound microscope, the pattern seen in healthy subjects is essentially the same-a dense mat of red areas interconnected by dark, irregular lines, completely filling the area of the drop. The blood of people under mycotoxic/oxidative stress exhibits a variety of characteristic patterns which deviate from nor­mal, but with one striking, common abnormality: “clear” or white areas, in which the fibrin net/red blood cell conglomerate is missing.

Why the fibrin net is missing may be understood from the following: Two peptides-A and B-in the central protein bead of the fibrinogen structure become bound in the cross-linking process. There are two ways this can be configured:

  1. Thrombin is capable of activating peptides A and B, resulting in the formation of a polymer loosely held together only by hydrogen bonds;
  2. With peptides A and B acti­vated normally, the resulting hard clot is insoluble, indicating that the peptides are linked by covalent bonds. The difference in bonds results from factor XIII, an enzyme which links the two fibrin strands with a glutamine-lysine peptide bond.

Additional research has shown that the release of sialic acid from fibrinogen inhibits the action of factor XIII, resulting in a soft, white clot. In addition, acetic aldehyde has been shown to inactivate factor XIII directly. The soft clotting, compounded by other polymeric aggregations (described below), results in clear areas in the dry specimens. In the opposite extreme, high serum levels of calcium, for the pur­pose of neutralizing MAT, activates factor XIII, lead­ing to excessive cross-linking of fibrin to form a clot harder than normal. This is reflected in the MOST pattern characteristic of definite hypercalcemia- that of a series of cracks in the clot radiating outward from the center, resembling the spokes of a wheel. High serum calcium is the body’s attempt to com­pensate for the acidity of mycotoxic stress by pulling this alkalizing mineral from bone into the blood. This demand creates endocrine stress in turn, because reabsorption of bone is mediated by parathormone (PTH). Therefore, this clotting pattern indicates cal­cium deficiency and thyroid/parathyroid imbalance (Monograph 4).

Monograph 4: A mineral deficiency or more specifically a calcium deficiency pattern associated with an imbalance of the thyroid and/or parathyroid.

Advanced research has shown that there are seven carbohydrate chains in fibrinogen (each terminated by sialic acid). A second action of factor XIII is to ferment a large amount of carbohydrate during clot­ting. Because carbohydrate is most often water solu­ble, the loss of this material undoubtedly adds to the insolubility of a clot, while pathological retention contributes to the softness of the abnormal clot.

Clinical experience demonstrates that the MOST is a reliable indicator of exotoxic and mycotoxic stress and, concurrently, of various disorganizing symptoma­tologies associated with fermentative and oxidative processes. As various cellular degradation occurs, the blood-borne phenomena which accompany such symptoms as diabetes, arthritis, heart attack, stroke, atherosclerosis and cancer show up in the MOST, often with sialic acid beads in the clear areas of poly­merized proteins. (Determination of the liberation of sialic acid from carbohydrate has been approved by the U.S. Food and Drug Administration as an accept­ed indicator for cancer, and is clinically available) (Monograph 5).

Monograph 5: Sialic acid beads are seen inside the protein polymerization of the hypocoagulated blood as black

The extent and shape of the clear areas are reflec­tive of particular symptomatologies which have arisen from the way in which the disease condition manifests in a given individual. This observation is borne out by having the patient undergo appropriate therapy. With success of treatment based on the patient’s freedom from symptoms, sense of well-being, and live blood exams discussed in the main text of Sick and Tired, Reclaim Your Inner Terrain, Appendix C [9], repeated analysis with the MOST reveals a progressively improving clotting pattern (Monograph 6A & 6B).

Monograph 6A & 6B: Medically diagnosed cancer patient with large polymerized protein pools (PPP) in the hypo-coagulated blood above. In the picture below PPP’s have significantly reduced in size and the blood is moving to a more hyper-coagulated state as a result of reducing acid loads with an alkaline lifestyle and diet [9,53].

Because of its very nature, the MOST is emi­nently suited to reveal and measure the presence in the blood of abnormal substances, clotting factors, and disorganization of cells due to an inverted way of living, eating, and thinking, which gives rise to MAT. The MOST indicates both the direct and indirect activity of MAT on blood clotting, endothelium, and the extracellular matrix (described next), as well as on biochemical pathways, including hormonal ones. The generation of excessive MOBS in response to EMPO and MAT, the inability that accompanies all degenerative symptoms to neutralize or eradicate EMPO and MAT, and the recognized hyper- and hypocoagulable states seen in various symptomatolo­gies, will beyond doubt be revealed in the MOST (Monograph 7A & 7B).

Monograph 7A & 7B: Medically Diagnosed HIV/AIDS micrograph showing above an Aspergullus niger mould crystal using dark field microscopy and below a hypocoagulated blood clot with systemic protein polymerizations measuring in excess of 40 microns using bright field microscopy.

As mentioned, hormones are easily fermented, and this will show up as a hypocoagulated blood pattern in the MOST. It is my opinion, this hypocoagulated blood appears in the MOST as misty clouds of protein polymerizations throughout the clot, as seen in the accompanying picture (Monograph 8).

Monograph 8: Poor fibrin interconnection in the clot associated with endocrine or hormonal imbalance.

The MOST from solubilized extracellular matrix: There is now a clearer picture of the biochemical rationale for correlating abnormal blood clotting patterns with the presence of degenerative symptoms.  A link between symptoms and the distorted clotted blood patterns has been delineated in the MOST.

Another reason for the abnormal clotting patterns accompanying pathological states, in addition to insufficient bonding of fibrinogen peptides as seen in the MOST, is presence in the blood of water-soluble fragments of the extracellular matrix.

Extracellular matrix degradation by MAT: The extracellular matrix (EM) is a three-dimen­sional gel, binding cells together and composed of five or more major constituents: collagen (protein), hyaluronic acid (polysaccharide), proteoglycans (pro-tein/polysaccharide), fibronectin and laminin. Also included are glycosaminoglycans and elastin [54]. In every degenerative disease studied by this author, evidence has been found for MAT activity destruc­tive of EM.

One of the proteolytic enzymes activated in response to EMPO and MAT is alpha-1 antitrypsin (capable of neutralizing MAT), normally not active in the presence of the enzyme trypsin. The active por­tion of this anti-exotoxin and antimycotoxin contains the amino acid methionine, which includes a C-S-C linkage. When chelated by the hydroxyl radical (one of the MOBS oxidants), methionine’s central sulfur atom acquires one or two oxygen atoms (forming the sulfone or sulfoxide respectively). The fermentation of methionine is a secondary effect of immune response to an alarming situation, intended to neutral­ize MAT and prevent degradation of the EM. Once alpha-1 antitrypsin is exhausted, MAT will have more access to the EM. If the EM is damaged beyond repair, then the enzyme trypsin is released to disorganize and recycle the cells involved [54].

A similar scenario holds for the enzymes collage- nase and elastase. Thus, the absence of alpha-1 antitrypsin in the presence of EMPO and MAT activates three enzymes which degrade the extracellular matrix. Degradation of the EM by enzymes and MAT puts into the blood the water-soluble fragments (proteins and glycoproteins) of normally insoluble EM components (Table 12). The presence of these fragments modifies the normal clotting pattern (described below), as seen in the M/OST, and is therefore an indication of EM degradation, which is always found with degenerative symptoms. (Also present is fibrin monomer, which has been found in the blood of patients suffering from collagen dis­ease [55] (Table 12).

Table 12: Most Blood Test and Disseminated Intravascular Coagulation with Solubilized Extracellular Matrix.

Fibronectin is a molecule in EM having several binding sites for various long-chain molecules- heparin (a sulfonated polysaccharide) and collagen, for example. As such, it functions as a cellular glue, bind­ing cells together as well as various components of the EM. A soluble form of fibronectin is normally found free in the blood, and enters into the formation of a blood clot through the action of factor XIII. This form of fibronectin binds to fibrin. Elevated, bound-serum fibronectin results from EM fragmentation by MAT, and accompanies degenerative symptoms such as arthritis and emphysema (collagen diseases).

Water-soluble fragments of the EM bound by fibronectin form a three-dimensional network or gel in the pathologically clotted blood (fibrin and com­ponents of the blood clotting cascade). Since fibronectin binds to both fibrin and collagen, the two polymeric networks are superimposed and intermin­gled, resulting in a modification of the normal clot­ting pattern. Exactly how the pattern is modified depends upon the nature of the collagen abnormally present, the nature and extent of hyaluronate pre­sent, and the degree to which EM fibronectin has been released by MAT.

Conclusion

Thus, it is easily seen that there are many forms which the pattern of clotted blood may take, depending on the individual and the internal terrain that produced the modifying substances. The MOST reveals not only the presence of exotoxic and mycotoxic stress, but indicates as well the nature of the symptom(s) resulting from the stress (Table 13). Since MAT underlie the entire complex of events which degrade the extracellular matrix, I must conclude that the absence of these exotoxins, endotoxins and mycotoxins would provide substantial improvements in tissue integrity and the overall physiology and functionality of the organism or animal and human.

Table 13: Typical Sources of Fermentation Insult (Mat) in Biological Systems Initiating Dic.

References

  1. Jones TW (1842) Observations on some points in the anatomy, physiology and pathology of the blood. British Foreign Medical Review p. 1-24.
  2. Trousseau A (1865) Phlegmasis alba delens. Clinque Medicale de L’Hotel Dieu de Paris 3: 94.
  3. Virchow R (1856) Hypercoagulability: A review of its development, clinical application, and recent progress. Gesammelte Abhandlungen our Wussenschaftlichen Medizin 26: 477.
  4. Rapaport SI (1993) Blood Coagulation and its Alterations in Hemorrhagic, and Thrombotic Disorders. West J Med 158(2): 153-161.
  5. Be Champ A (1999) The Blood and Its Third Anatomical Element. Hikari Omni Publishing, USA.
  6. Schwerdtle C, Arnoul F, Enerlein G (2006) Introduction to Darkfield Diagnostics. Semmelweis-Verlag, Germany.
  7. (1994) The Harper Collins Illustrated Medical Dictionary, p.13.
  8. Hamilton PJ, Stalker Al, Douglas AS (1978) Disseminated Intravascular Coagulation: A Review. Journal of Clinical Pathology 31: 609-619.
  9. Young RO (1999) Sick and Tired, Reclaim Your Inner Terraine. Woodland Publishing, USA.
  10. Hawk BO, Thoma GE, Inkley JJ (1951) An Evaluation of the Bolen Test as a Screening Test for Malignancy. Cancer Res 11(3): 157-160.
  11. Uchida K (2000) Role of Reactive Aldehyde in Cardiovascular Diseases. Free Radic Biol Med 28(2): 1685-1696.
  12. Chang JC, van der Hoeven LH, Haddox CH (1978) Glutathione reductase in the red blood cells. Ann Clin Lab Sci 8(1): 23-29.
  13. Kutzing MK, Firestein BL (2008) Altered Uric Acid Levels and Disease States. J Pharmacol Exp Ther 324(1): 1-7.
  14. Claudino M, Ceolin DS, Alberti S, Cestari TM, Spadella CT, et al. (2007) Alloxan-Induced Diabetes Triggers the Development of Periodontal Disease in Rats. Plos One 2(12): e1320.
  15. Young RO (2015) Alkalizing Nutritional Therapy in the Prevention and Reversal of any Cancerous Condition. IJCAM 2(1): 00046.
  16. Fernandes HP, Cesar CL, Barjas Castro Mde L (2011) Electrical properties of the red blood cell membrane and immunohematological investigation. Rev Bras Hematol Hemoter 33(4): 297-301. 
  17. Harris JO A study of The Relationship Between the Surface Charge and the Absorption of Acid Dyes by Bacterial Cells. J Bacteriol 61(6): 649-652.
  18. Young RO (2016) Metabolic and Dietary Acids are the Fuel That Lights the Fuse that Ignites Inflammation that Leads to Cancer. Int J Complement Alt Me 3(6): 00094.
  19. Snaders R (2012) Did Bacteria Spark Evolution of Multicellular Life? Berkeley News, USA.
  20. Wenner M (2007) Humans Carry More Bacterial Cells than Human Ones. Scientific American, USA.
  21. Animals and humans respond to MAT as a poison.
  22. Morrison DC, Ulevitch RJ (1978) The effects of bacterial endotox­ins on host mediation systems. Am J Pathol 93(2): 526-618.
  23. Van Deventer SJ, ten Cate JW, Tytgat GN (1988) Intestinal endotoxemia. Clinical significance.Gastroenterology94(3): 825-831.
  24. Morrison DC, et al. op. cit.
  25. Hu T, Bach RR, Horton R, Konigsberg WH, Todd MB (1993) Synthesis of tissue factor messenger RNA and procoagulant activity in breast cancer cells in response to serum stimulation. Thromb Res72(2): 155-168.
  26. Mackman N, Brand K, Edgington TS (1991) Lipopolysaccharides-mediated tran­scriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med174(6): 1517-1526.
  27. Yamada O, Charles F Moldow, Sacks T, Philip R Craddock, Boogaerts MA, et al. (1981) Deleterious effects of endotoxins on cultured endothelial cells: An in vitro model of vascular injury. Inflammation5(2): 115-126.
  28. M Colucci, G Balconi, R Lorenzet, A Pietra, D Locati et al(1981) Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 71(6): 1893-1896.
  29. Cho TH et al. Effects of Escherichia coli toxin on structure and permeability of myocardial capillaries. Acta Pathol Jpn 41(1): 12-18.
  30. Margolis J (1963) The interrelationship of coagulation of plasma and release of peptides. Annals of the New York Academy of Sciences104: 133-145.
  31. Morrison DC, et al. op. cit.
  32. Alberts B, et al. (1986) Molecular Biology of the Cell(2nd edn)Garland Publishing, New York, USA, pp. 818.
  33. Nachman RL, et al. (1993) Hypercoagulable states. Annab of Internal Medicine119: 819.
  34. Tallman MS, Hakimian D, Kwaan HC, Rickles FR (1993) New insights into the pathogene­sis of coagulation dysfunction in acute promyelocytic leukemia. Leuk Lymphoma11(1-2): 27-36.
  35. Silberberg JM, Gordon S, Zucker S (1989) Identification of tissue factor in two human pancreatic cancer cell lines. Cancer Res 49(19): 5443-5447.
  36. Grimstad IA, Prydz H (1988) Thromboplastin release, but not content, correlates with spontaneous metastasis of can­cer cells. Int J Cancer41(3): 427-431.
  37. Gunji Y, Gorelik E (1988) Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells. Cancer Res 48(18): 5216-5221.
  38. Sugiyama S, Hayakawa M, Hanaki Y, Hieda N, Asai J, et al. The role of leukotoxin (9, 10- epoxy-12-octadecenoate) in the genesis of coagulation abnormalities. Life Sci 43(3): 221-227.
  39. White A, et al. (1964) Principles of BiochemistryMcGraw-Hill Book Co., New York, USA, pp. 648.
  40. Mueller HE, et al. (1972) Increase of microbial neu­raminidase activity by the hydrogen peroxide concen­tration. Experientia23: 397.
  41. Robert OY (1994) Fermentology and oxidology. The study of fungus-produced mycotoxic species and the activation of the immune system and release of microzymian oxidative buffering species (MOBS). Inner Light Biological Research Foundation, Alpine, Utah, USA.
  42. Chandler WL, Schmer G (1986) Evaluation of a new dynamic vis­cometer for measuring the viscosity of whole blood and plasma. Clin Chem 32(3): 505-507.
  43. Saleem A, Blifeld C, Saleh SA, Yawn DH, Mace ML, et al. (1983) Viscoelastic measurement of clot for­mation: A new test of platelet function. Ann Clin Lab Sci 13(2): 115-124.
  44. Spillert CR, Passannante MR, Salzer Pagan JE, Lazaro EJ (1993)Altered coagulability: An aid to selective breast biopsyJ Natl Med Assoc85(4): 273-277.
  45. Bowie EJ, Owen CA (1983) The clinical pathology of intravascular coagulation. Bibl Haematol 49: 217-224.
  46. Berghaus MG, Eckhardt T (1975) The role of granulocytes in the activation of intravascular coagulation and the pre­cipitation of soluble fibrin by endotoxin. Blood 45(5): 631-641.
  47. Bick RL (1993) Disseminated intravascular coagulation. Hematology/Oncology Clinics of North America 6: 1259.
  48. Bredbacka S, Blombäck M, Wiman B, Pelzer H (1993) Laboratory methods for detecting disseminated intravascular coagulation (DIC): New aspects. Acta Anaesthesiol Scand37(2): 125-130.
  49. Sigma Diagnostics, St. Louis, USA.
  50. Gurewich V, Hutchinson E (1971) Detection of intravascular coag­ulation by a serial-dilution protamine sulfate test. Ann Intern Med 75(6): 895-902.
  51. Breen FA, Tullis JL (1970) Ethanol gelation: A rapid screening test for intravascular coagulation. Ann Intern Med69(6): 1197-1206.
  52. Hay ED (1991) Cell Biology of Extracellular MatrixPlenum Press, Springer US, New York, pp. 653.
  53. Carp H, Janoff A (1979) In vitro suppression of serum elastase- inhibitory capacity by ROTS generated by phagocytos- ing polymorphonuclear leukocytes. J Clin Invest 63(4): 793-797.
  54. Wilson CL, Schwarzbauer JE (1992) The alternatively spliced V region con­tributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots. J Cell Biol119(4): 923-933.
  55. Fernandes HP, Cesar CL, Barjas Castro Mde L (2011) Electrical properties of the red blood cell membrane and immunohematological investigation. Rev Bras Hematol Hemoter 33(4): 297-301. 

The Worlds Top 5 Diets for Health, Fitness and Beauty

Number 1: The pH Miracle Alkaline Lifestyle and Diet

 

Victoria Beckham keeps her slender physique in shape by following the pH Alkaline Lifestyle and Diet, recommended by Robert O. Young PhD. This plan means you ingest ONLY alkaline foods and liquids to keep your acidic levels in your blood, interstitial fluids, intracellular fluids at an alkaline pH between 7.35 and 7.45. All of these fluids can be tested with the Full-Body 3-D Bio-Electro Scan and the non-invasive blood testing of the chemistry, including pH of the blood, stomach, intestines and interstitial fluids. To learn more about these non-invasive medical tests click here: (http://www.universalmedicalimaging.com/index.html

The following chart lists some of the acidic foods on the pH Miracle Alkaline Diet to eliminate completely or eat sparingly:

The following chart lists some of the foods you can eat freely on the pH Miracle alkaline diet:

The supermodel Elle Macpherson stated that following a plant-based pH Miracle alkaline lifestyle and diet and taking supplements have helped her look younger than her 54 years. (wwwijuicenow.com and http://www.phoreveryoung,com)

Screen Shot 2018-09-28 at 6.35.07 AM

 

“When I turned 50 I realized things I did in my 20s weren’t working anymore,” Macpherson said. “I follow a plant-based alkaline diet, focusing on healthy, whole food. I take green powder and protein powder every day, and I drink three litres of water a day.” (www.ijuicenow.com, http://www.phoreveryoung.com)

So where does a 6’7″ man who weighs over 270 pounds get his protein from? Tony Robbins eats broccoli! Over 50 percent of the calories from steamed organic broccoli comes from protein. It is important to note that the body does not build muscle from protein – it builds it from red blood cells. Muscle, bone, and all organs and glands are made from red blood cells NOT protein! Tony is a strong advocate and walking testimony of Dr. Young’s alkaline lifestyle and diet which he teaches from the stage at ALL his events.

Screen Shot 2018-09-30 at 11.29.12 AM

Number 2: The Vegan Diet

 

Beyonce is a big fan of Marcos Borges 22 days of Vegan program which is a vegan meal service. Although not a full vegan, the singer ordered in the service to get in shape for Coachella. “The benefits of a plant-based diet need to be known,” Beyoncé said. “We should spend more time loving ourselves, which means taking better care of ourselves with good nutrition and making healthier food choices.”

The following are just a few of the foods I recommend that you can eat freely when following an Vegan Diet as outlined in The pH Miracle revised and updated book and The pH Miracle for Weight Loss – http://www.phoreveryoung.com

Number 3: Ancient Grains

 

To keep her energy levels at an all-time high, Angelina Jolie snacks on ancient grains such as quinoa, chia seeds, millet, buckwheat and spelt. “She’s into eating products made from ancient grains and raves about their health benefits,” a source told Marie Claire. “She claims they provide her with nutrients she can’t find anywhere else, plus shinier skin.”

The wonderful benefits of ancients grains like quinoa, millet, buckwheat and spelt are they are low carbohydrate and higher in protein. Keep in mind though I only recommend these grains sparingly.

Number 4: Paleo

 

Jessica Biel credits her super svelte physique down to the Paleo diet. Heavily endorsed by Pete Evans, the diet works on the ethos you go back to eating like a caveman and eradicate dairy, grains and legumes from your diet. “Eating Paleo just leans you down and slims you up and takes that little layer of fat and water-weight right off your body,” says Jessica. “I do a lot of cooking at home using fresh fish or lean meat like chicken and vegetables,” she adds.

The Paleo diet will provide short term benefits but long term damage from ALL the acidic foods from dairy, legumes and grains such as wheat. You are better off with short and long term benefits by sticking with a diet that does not cause eventual gland, organ and tissue damage.

Number 5: The Atkins Diet

Kim Kardashian lost 25 kilos in 11 months on the Atkins diet, which is a high acidic protein, low carb diet. “ Anyone who has had kids knows your body changes, and it’s hard to get your body back in shape,” she said. “It takes so much determination, and mental and physical power and energy.”

Unfortunately this diet also has short term benefits with long term damage, especially to the intestinal villi if you are ingesting animal protein which does not digest (unless you juice the animal flesh). Maybe that is why Kim looks bloated in the lower abdominal area. It is important to stay away from this diet unless your protein sources are from green plants such as avocado, broccoli and buckwheat. Check out the above list of foods to avoid and especially avoid animal sources for safe and healthy weight loss.

 

For safe and effective weight loss read The pH Weight Loss by Robert O Young PhD – http://www.phoreveryoung.com or on amazon.com at: https://www.amazon.com/gp/product/0446694703/ref=dbs_a_def_rwt_hsch_vapi_taft_p1_i1

Maryanne lost over 150 pounds following The pH Miracle for Weight Loss Lifestyle and Diet.

Jacob lost over 100 pounds in 12 weeks following The pH Miracle for Weight Loss lifestyle and diet plan.

A NEW Study Finds Dietary Acid Load Increases Risk for Breast Cancer and an Alkaline Diet Reduces Risk for Breast Cancer Validating the Work, Research and Published Findings of Robert O. Young

Screen Shot 2018-09-28 at 7.32.39 AM(An electron micrograph of a cancerous breast condition highlighted in purple)

Higher Diet-Dependent Acid Load is Associated with Risk of Breast Cancer: Findings From the Sister Study

International Journal of Cancer — Mark Park YM, et al. | September 26, 2018

Researchers assessed the link between diet-dependent acid load and risk of breast cancer, using multivariable Cox proportional hazards regression as well as data from 43,570 Sister Study participants who completed a validated food frequency questionnaire at enrollment (2003-2009) and satisfied eligibility criteria. They estimated diet-dependent acid load by using the Potential Renal Acid Load (PRAL) score; a greater consumption of protein and phosphorus, and lower consumption of potassium, calcium, and magnesium was indicated by higher scores. According to findings, higher diet-dependent acid load could confer risk, while alkaline diets could protect against the risk for breast cancer. In addition, development of hormone receptor negative breast cancer could be reduced by consuming diets high in fruits and vegetables and low in meat because findings demonstrated a positive correlation of PRAL scores with meat consumption and negative correlation with fruit and vegetable intake.

What is the Cause of Cancer including Breast Cancer?

A rise in the alkalinity of the blood above pH 7.365 (alkaline phosphate)—any rise—is a result or a compensatory reaction due to over-acidity in body tissues as the blood attempts to maintain pH balance. There is no exception for the rule of alkalinity.

The body will ALWAYS overcompensate for the excess acidity in the interstitial fluids and then tissues by over-alkalizing the blood to maintain homeostasis. I call this the “teeter-totter” effect. Along comes the traditional medical attendant and perceives that there is too much alkalinity, when really there is not.

 This is an important concept to grasp, so let’s oversimplify a bit. The tissues have become acidic. The blood “knows” that. So, it pours out extra alkalinity or alkaline phosphate into the blood and the blood pH spikes up to a higher than normal pH. It’s like when we get the bejeebers scared out of us by something innocent, we over-react. When suddenly alarmed, a person might scream, holler, faint, get mad, strike out, drop the vase, kick the dog, or even have a heart attack. The blood does the same thing. A knee-jerk reaction…well, actually, a blood-jerk reaction.

Alternatively, how many times have you heard of a car going off the shoulder of the road and the driver over-reacts, jerks the wheel back, and flies into the other lane of oncoming traffic. It happens all the time. Incidentally, if that does happen to you, you’re better off not to interfere. Stay on the shoulder. Let the wheel stay there for a moment. Slow the car down. But don’t overreact.

Mainstream medicine, not understanding the cause of the excessive alkalinity pouring into the body, may try and stop the rushing over-alkalization. But that’s the wrong move. We’re better off not to interfere.

Once more. When your little boy falls down, sees mama going out the door, or is scared of the boogey man, what happens? He not only cries, but how often do we see a child go into a big, fat over-reaction? Sometimes, they really get worked up. It’s a natural over-reaction to a typical situation.

Now it’s Dad’s turn to over-react. Along comes Dad and says to keep quiet, shut-up, don’t be such a little sissy, put a lid on it, grow up, stop that crying, OR ELSE…

Since I have digressed to make a point, I may as well digress all the way. Wrong move, Dad. If you do that often enough, the message you send to your child is don’t have feelings, don’t express your feelings, you are not acceptable, don’t act like a child even though you are a child, and don’t be who you are. So don’t over-react Dad. Better to let the child get it out, stay in the room, validate their feelings, and use a little Active Listening (www.gordontraining.com). Strong feelings can come and go…or come and stay. If you’re really klutzy, you could be orchestrating chronic emotional issues for a lifetime. Gee, thanks Dad.

Now, back to your blood and interstitial fluids. Tissues are acidic because the interstitial fluids are acidic.

Here comes a flood of alkalinity—even so much that the pH rises and concerns the western medical establishment. But whatever it was that caused the pH to over-react must be understood. Acidic tissues mean problems ahead, correct? Not only do we need alkalinity but lots of it. The acidic interstitial fluids of the Interstitium will soon even out the rise in blood pH, and we will need additional alkalinity to wipe out the acidic tissue or cellular problem.

Breast Cancer is Not a Disease of Alkalinity but a Disease of Acidity

The body uses the calcium of the bones as well as other buffers (bicarbonate, hemoglobin, sodium, etc.) to chelate acidity! That is why there are always micro-calcifications in the breast before the breast cancer tumor shows up. Why prior to the tumor? Because the body will always try to protect and preserve itself by buffering acids with the alkalinity of calcium. The bones are always affected in any cancerous condition because the bones are an excellent source for calcium.  So is breast cancer the disease? No.

Then is the loss of bone mass the disease or the calcium deposits in the breast the disease. NO?

Is the increase in the alkaline phosphates the disease? NO! NO!

These are all symptoms, not diseases!

Then the disease must be the over-acidity? Well yes, and well no.

Then what is the disease? The “yes” part I call acidosis or hyperacidity.

(An electron micrograph of a cancerous breast condition highlighted in purple)

 

That is an acceptable term for the condition. But it is really much more. The “no” part is that it’s more than acidity. It’s a psychological disorder. It’s a sociological malaise. It’s a cultural-anthropological phenomenon. And once people understand the truth and the scientific foundation of New Biology, and once people understand the science of what I have been writing about for two the better part of two decades, it may then become to be understood as a “moral disease” as well.

And why is that, you ask? Is committing suicide a moral issue? Well, yes. Is drinking yourself to death a moral issue? Well, yes. Is allowing your children to become obese flying in the face of natural law? Well, yes, assuming you are aware of what’s happening and have other options.

If you say “yes” to these last few questions, then we are looking at a very, complex psychological, sociological, cultural, biological and moral phenomenon. Once you know and believe that over-acidity causes every disease and most dis-ease, then to ignore that fact is a form of suicide. When you eat poorly, you pull the trigger every day of your life, and eventually, the gun fires. The bullet might hit you square in the head like a massive heart attack, or it may kill you more slowly like a cancer, or it may simply put you in a fog for the next 15 years like Alzheimer’s or dementia.

This “Disease-Phenomenon” is Simple! 

The “disease-phenomenon” is an inverted way of living, eating and thinking!!! Yes, this is the cause of ALL disease—ALL that disturbs the central balance of organized matter that leads to excess acidity. It is ALL that leads to increases in alkaline phosphates. It is ALL micro-calcifications in the breast tissue, ALL micro-calcifications of the liver and ALL breast and liver tumors, ALL breast and liver cancers and ALL potential bone cancer!!!!

First, we must understand that ALL of the above sicknesses and diseases are NOT sicknesses or diseases but a symptom of acidosis and catarrh that has built up in the blood and then interstitial fluids and then tissues that has significantly effected the white blood cells’ ability (the janitorial and garbage collectors for the blood and tissues) to remove metabolic acids and morbid matter. When we are dealing with any symptom or any effect, we need to look to the cause. To understand the cause is not difficult nor is the understanding of the treatment.

The New Biology

The “New Biology” explains the cause and effect of all sickness and disease in addition to explaining how to improve the quality and quantity of life.For example, enervation (the deprivation of force or strength) and muscle weakness per se is not a disease. Weakness, or lost power, is not a disease; but, by causing a flagging of the elimination of tissue-waste of the fluids which are toxic, the blood and then interstitial fluids of the Interstitium become charged with acids.

 I call this Acidosis—poison in the blood, interstitium and tissues. This is disease and when the toxin accumulates beyond the toleration point, a crisis takes place. This means that the poison or acid is being eliminated—often through the pores of the skin, the third kidney. WE can call this disease, but it is not. The only disease is systemic Acidosis which localizes in the weakest parts of our body or in the fatty tissues such as the breast tissue.

The Acidic Pathway to a Cancerous Condition

And what we call disease is symptoms produced by the forced vicarious elimination of acids from the Interstitium through the mucous membranes. When the elimination takes place through the mucous membrane of the nose, it is called a cold—catarrh of the nose. And where these crises are repeated for years, the mucous membrane thickens and ulcerates, and the bones enlarge, closing the passages. At this stage, hay fever or asthma develops. When the throat and tonsils, or any of the respiratory passages, become the seat of the crises of acidity, we have croup, tonsillitis, pharyngitis, laryngitis, bronchitis, asthma, pneumonia, etc.

When the acids locate in the cranial cavity we have dementia, Parkinson’s, Alzheimer’s, muddle thinking, forgetfulness, and even depression. When the acids locate in the gastrointestinal tract we have IBS, gastrointestinal dysmotility, autonomic dysfunction, carotid stenosis and ischemic colitis. When the acids are expressed through the skin we have psoriasis. When the acids locate in the breast and/or liver tissues we have micro-calcifications of these acids that lead to tumors and cancer.

What’s in the name?

All are symptoms of the expulsion of acids from the blood into the interstitial fluids and then fatty tissues at the different points are named. They are of the same character essentially and evolve from the one cause, namely, systemic dietary and metabolic acidosis, a crisis of systemic toxemia.

The description can be extended to every organ of the body, including the largest organ, the Interstitium. For any organ that is enervated below the average standard from stress of habit, from work, or worry, from injury, or any other cause, that organ may become the location of the crises of systemic dietary and metabolic acidosis. The symptoms presented differ with each organ affected. That fact gives color to the erroneous belief that every symptom-complex is a separate and distinct disease. But, thanks to the new light being shed by my  “New Biology” upon nomenclature involved in the naming of a disease, every symptom-complex goes back to the one and only cause of ALL diseases, namely, systemic dietary and metabolic acidosis.

The Pathology of Cancer Begins with Dietary Acid

To find the cause of all symptomologies including breast, liver and bone cancer, start with colds and catarrh, and watch the pathology as it travels through the seven stages of acidity, from sensitivity, irritation (IBS), catarrh, inflammation, induration (lupus), ulceration and then to degeneration—cancer. How well could you try to find the cause of man by ignoring his conception, embryonic life, childhood, manhood, etc.

Nature’s order is interfered with by enervation habits until dietary and metabolic acidosis is established. Then a vaccination (seen in Gulf War Syndrome and Spanish Flu Epidemic) or an infection (I refer to an outfection) from any source will act as a firebrand. Sooner or later cause the most vulnerable organ (the bowels) will undergo organic change. The organ, however, has nothing to do with cause, and directing treatment toward the organ compounds the problem and is nonsense. Examples of this wrong thinking yield blood transfusions for pernicious anemia, hormonal gland treatment for gland impotency, the cutting out of stones, ulcers and tumors.

There is no question that one of the most pernicious practices in vogue today is treating so-called disease with disease and immunizing with the products of disease. Current medical science calls this form of pathological thinking a “vaccination.”When the cause is not known, how is prevention or cure possible except by luck? Producing a mild form of smallpox using vaccine is the same as introducing a poison into a healthy person. It makes no sense. Certainly only pathological thinking can arrive at such conclusions. Vaccine or autogenous remedies (metabolic acids) are made from the products of disease. The idea that disease can be made to cure itself is an end-product of pathological thinking!

Prevention NOT Treatment is the Cure for Cancer

If prevention and cure mean producing disease, surely prevention and cure are not desirable. If prevention can be accomplished, then cures will not be needed!It is not disease, it is cause “in all its aspects” that we need to know before we can take steps to prevent or cure “disease.”Cause is constant, ever present, and always the same. Only effects, and the object on which a cause acts, change. And the change is most inconstant.

To illustrate: a catarrh of the stomach presents first irritation, then inflammation, then ulceration, and finally induration and finally cancer.

Not all cases run true to form. Only a small percentage evolve to ulcer and fewer reach the cancerous stage. More toxins exit via acute food poisoning or acute indigestion then by chronic diseases. Most Americans are challenged with the symptomology of indigestion, which can include acid reflux, diarrhea and/or constipation.The proper way to study disease is to study health and every influence favorable or not favorable to its continuance. Our western system of medicine has been preoccupied with the study of disease, not health. Disease is perverted health. Any influence that lowers energy becomes disease producing. Disease cannot be its own cause, neither can it be its own cure and certainly not is own prevention!

Over 35 Years of Acid and Alkaline Research

My personal discovery of the truth of ALL sickness and disease—that dietary and metabolic acidosis is the cause of ALL so-called diseases—came about slowly, step by step, line upon line, precept upon precept, here a little and there a little.

At first, I postulated that yeast and molds must be the general cause of disease. Then I decided that it was not yeast and molds but that the body becoming enervated. But wait a minute, enervation is not a disease; disease must be due to metabolic acids. I reasoned that localized or systemic dietary and metabolic acidosis is the true general cause of all disease and must be auto-generated. And, if disease is due to auto-generated acids, what is the cause of that auto-generation?

The answer is found in understanding the nature of matter and how it organizes and disorganizes. I realized that there must be a physical or emotional disturbance to organized matter before it can begin its disorganization. And when matter begins to disorganize, it gives rise to auto-generated acids. This is true for all matter!

The Acid and Alkaline Theory – An Illustration

To illustrate, take a physical injury to a joint which is often complicated with the prior symptom of rheumatism. The rheumatism previous to the injury was potentially in the blood and/or tissues. Just what change had taken place in the matter which, under stress of injury or shock of any kind, would cause a reaction with fever? I could not understand until the “Acid and Alkaline Theory” suggested itself to my mind. After that, the cause of disease unfolded before me in an easy and natural manner. I called this new paradigm for ALL sickness and disease “The Cycle of Imbalance.” You can read about “The Cycle of Imbalance” in my book, “Sick and Tired, Reclaim You Inner Terrain.” You can order this book at: www.phmiracleliving.com.

In a few words, without dietary and metabolic acidosis, there can be no sickness or disease and there can be NO CANCER! It is also true that without dietary and metabolic acidosis there can be NO PAIN! Therefore, pain equals acid and acid equals pain. I knew that the waste products of cellular disorganization, metabolism and diet were toxic and that the only reason why we were not poisoned by it was because it was removed from the organism as fast as it was produced into the interstitial fluids of the Interstitium.

Enervation Was Caused by Elimination

Then I discovered that the acid was retained in the interstitial fluids and then the fatty tissues when there was a checking of elimination. Then, the cause of the checking had to be determined. In time, I thought out the cause of all sickness and disease. I knew that when we had normal energy, organic functioning was normal. Then came the discovery that enervation caused a checking of elimination.

Eureka! The Cause of ALL Sickness and Disease is NOW Found!

Enervation checks elimination of the waste-products — ACIDS — from cellular disorganization, metabolism and DIET!  Retention of metabolic and dietary ACIDS is the first and the only cause of sickness and disease!

One of the first things to do to get rid of any so-called disease is to get rid of all the acid, for it is this state of the blood, interstitial fluids and fatty tissues that makes disease possible. Infection, drugs and food poisoning may kill, but if they do not, they will be short-lived in a subject that is free from enervation and acid. Conversely, the poisoning will linger in the system until the acid is overcome. Then and only then will elimination remove all traces of the outfection NOT the infection!

Syphilis and HIV

Syphilitic outfection is pronouncedly an acidic subject thrown into great virulence by poor nutrition, lifestyle and conventional acidic treatment. The same is true with HIV/AIDS. The so-called outfection is the least offender of the trio. Add fear (false evidence appearing real) and wrong eating and we have a formidable symptom complex that serves to justify all that professional syphilomaniacs say and write about the disease.

Remove metabolic and dietary acidosis, drugging, fear, and vile eating, and there is little left. What is left can be easily thrown out of the body by Nature!

Scientific research is being carried on vigorously in an attempt to find the cause of disease. The conception of disease is that the cause is individual. Here is where investigators meet their Waterloo. All of the so-called diseases are increasing symptom complexes due to repeated crises of metabolic and dietary acidosis. They have no independent existence! As soon as acidity is controlled, the symptoms disappear unless an organ has been forced by innumerable crises to degenerate. Even organic change, when the organ is not destroyed, will come back by correcting the life and getting rid of the true cause—the crisis of acidosis!

All Disease Has One Origin

All symptoms of all so-called diseases have one origin. All diseases are ONE!  Unity in all things is Nature’s plan. Polytheism is gone, and everything pertaining to it and coming out of it must go.

So there is only one sickness, one disease, and NOW one treatment. The one sickness and disease is the over-acidification of the blood, interstitial fluids and then the fatty tissues due to an inverted way of living, eating, and thinking.

The One Non-Invasive and Non-Medical Treatment

The one treatment is to alkalize and energize the body fluids with the pH Miracle alkaline lifestyle and diet. You can learn more about this program on our website or in our books, The pH Miracle for Cancer, The pH Miracle, The pH Miracle for Diabetes, The pH Miracle for Weight Loss, Back to the House of Health I and II and Sick and Tired which you can also purchase through Amazon.com, Barnes and Noble or pHoreveryoung.com.

The complete program is a 12 week program that includes the foods outlined in the foundational section of the , “Back to the House of Health” ! and 2 books. You start off the program with a 14 day liquid feast. You can eat as much and as often as you like as long as the food is green, purred and/or juiced. The soups found in the pH Miracle books such as the Broccoli Soup, Aspar/Zinc Soup, The Healing Soup and the Popeye Soup with lots of avocados are excellent to eat during the liquid feast. You also need to begin taking the nutritional supplements while drinking at least 4 to 6 liters of iJuice Super Greens and iJuice Super Chlorophyll each day.

Start out gradually drinking 1 liter of iJuice Super Greens with iJuice Super Chlorophyll per day and then work up to 2, then 3, then 4, until you are drinking 6 liters green fluids a day. (www.ijuicenow.com)

When you take the pH Miracle and iJuice nutritional supplements, take 5 drops 6 times a day of the liquid colloids under the tongue, (except the pH drops which are taken in purified water and NEVER taken under the tongue) away from meals, or taking 1 capsule 6 times a day of the capsule products with meals. I would suggest taking 4 capsules every 4 waking hours of the bowel cleansing formula. The pH Miracle Core Cleanse cleansing product helps to keep things moving through normal elimination.

After you complete the 14 day liquid feast, you can then begin introducing some solid food but it still needs to be as green as possible. I would suggest not only the vegetable soups, but steamed vegetables and lots of salads. Make sure you use only lemon or lime and good oils of avocado, olive, and hemp on your salads for the dressing. Another tip is to include liberal amounts avocado and olive oil in or with your soups and salads. I suggest a minimum of 3 to 4 tablespoons of good oils each day.

No Need for Cures

In conclusion, the medical world has been looking for a remedy to cure disease, notwithstanding the obvious fact that nature needs no remedy. She needs only an opportunity to exercise her own prerogative of self-healing Cures! There are NO cures! The subconscious builds health or disease according to OUR ORDER. If we send impulses of irritation, discontent, unhappiness, complaining, hate, envy, selfishness, greed, lust, and the biggest one of all pride, the subconscious builds us in the image of OUR ORDER!

The truth is that we need no doctor. We need to empower ourselves to effect a reconciliation between our subconscious creator and ourselves.

What we need is to learn self-control, respect, poise, and relaxation! And when these impulses are sent over the sympathetic nerves to our subconscious creator, we will begin to receive images of a more ideal man or woman, until an approach to ‘Perfection is Attained’.

We don’t GET sick and tired we DO sick and tired!

Sickness and disease, including the symptoms of cancer, tumors, AIDS, diabetes, MS, lupus, HIV/AIDS, depression, hyperthyroidism, Wilson’s Syndrome, fybromyalgia, pain in every joint and muscle, chronic fatigue syndrome, muscle cramps, allergies (food), asthma, bronchitis, frequent colds, candida, hypoglycemia, allergic reaction to any chemical, chronic fatiguing, food cravings, indigestion, inflamed joints, insomnia, mood swings, gas, bloating, diverticulitis, irritable bowel, pneumonia, ulcers, stomach and bowel cramps and even memory loss is the culmination of years of abuse of nutrition and years of acids from faulty elimination by forcing the bowels to move. We don’t GET sick and tired we DO sick and tired! The most powerful way to eliminate dietary acids in the blood, interstitial fluids and fatty tissues is the pH Miracle alkaline lifestyle and dietary plan.

With Cancer Nothing Will Happen – The Inevitable Will Come

You are the builder of tomorrow, and you need not pay a fortune-teller, doctor, lawyer, preacher, or banker to tell you what will happen to you tomorrow. Nothing will happen. The inevitable will come. You will inherit the fruits of today’s sowing.

To learn more or to attend a pH Miracle Retreat go to: http://www.phmiracleretreat.com, http://www.drrobertyoung.com

Dr. Young Presents His Break-Through Research at the Annual Conference on Bacterial, Viral and Infectious Diseases in Dubai, U.A.E.

Do not miss the opportunity to attend the hashtag #workshopconducted by one of the top research scientists in the world, hashtag #Dr. Robert. O. Young, a world-renowned published hashtag #scientisthashtag #microbiologisthashtag #nutritionist, certified hashtag #phlebotomist and hashtag #naturopathicpractitioner at the Annual Conference on Bacterial, Viral and Infectious Diseases to be held in hashtag #Dubai, U. A. E, hashtag #December 05-06, 2018 hashtag #Call for abstracts hashtag #Early bird waivers

To learn more read the following published articles in the International Journal of Vaccines and Vaccinations – https://medcraveonline.com/IJVV/IJVV-02-00032.php

The Possible Cause of Polio, Post-Polio, CNS, PVIPD, Legionnaires, AIDS and the Cancer Epidemic – Mass Acidic Chemical Poisoning?

By Robert O Young CPT, MSc, DSc, PhD, Naturopathic Practitioner

Universal Medical Imaging Group, USA

International Journal of Vaccines and Vaccinations

Published: Nov 14, 2016 | pg. no: 1-24

Abstract: There is now over 100 years of documented history and research on the Polio virus and whether or not its treatment by inoculation has been successful in eradicating Polio. I am suggesting in this article that there are significant findings based on historical and past and current research, including my own research that the theory of Polio and possibly other modern-day diseases, such as Post-Polio Syndrome, Polio Vaccine-Induced Paralysis, Legionnaires, CNS disease, Cancer and AIDS may be caused by acidic chemical poisoning from DDT (dichloro-diphenyl-trichloroethane) and other related DDT pesticides, acidic vaccinations, and other factors including lifestyle and dietary factors rather than from a lone infectious Poliovirus. The following eleven graphs outline the history of Polio, the production of DDT, BHC, Lead, Arsenic, Polio vaccinations and the author’s theory that chemical poisoning, vaccination, and lifestyle and dietary choices are a more likely cause for the symptoms of Polio, neurological diseases, Cancer and AIDS.

To learn more read the following published article – http://www.phoreveryoung.com

Second Thoughts About Cover copy

Dismantling the HIV AIDS Viral Theory

The “HIV Virus” and other so-called viruses are used as examples.

Why should we doubt the existence of the HIV virus?

What are viruses? How are viruses being scientifically demonstrated to exist?

Do We Know the True Cause of HIV/AIDS?

Read and Learn the Answers to these Questions and More!

Do YOU Believe in the Viral Theory? – Part 1

Please read Part 1, 2 and 3 of the following published scientific article by Robert O Young CPT, MSc, DSc, PhD, Naturopathic Practitioner, and learn the truth about viruses, vaccines and the HIV/AIDS Hypothesis.

Second Thoughts Concerning Viruses, Vaccines and the HIV/AIDS Hypothesis – Part 1 HIV/AIDS and the Monomorphic Disease Model – http://medcraveonline.com/IJVV/IJVV-02-00032.php

The first isolation of a virus was achieved in 1892 by Russian bacteria hunter Dimitri Iwanowski, who gathered fluid from diseased tobacco plants. He passed this liquid through a filter fine enough to retain bacteria; yet to Iwanowski’s surprise, the bacteria-free filtrate easily made healthy plants sick. In 1898 a Dutch botanist, Martinus Willem Beijerinck, repeating the experiment, also recognized that there was an invisible cause and named the infectious agent “tobacco mosaic virus.” In the same year as Beijerinck’s report, two German scientists purified a liquid containing filterable viruses that caused foot-and-mouth disease in cattle (viruses were at one time called “filterable viruses,” but eventually the term “filterable” came to apply only to viruses, and was dropped). Walter Reed followed in 1901 with a filtrate responsible for yellow fever, and soon dozens of other disease-causing viruses were found.

In 1935 another American, Wendell M. Stanley, went back to the beginning and created pure crystals of tobacco mosaic virus from a filtered liquid solution. He affirmed that these crystals could easily infect plants, and concluded that a virus was not a living organism, since it could be crystallized like salt and yet remain infectious. Subsequently, bacteriologists all over the world began filtering for viruses, and a new area of biology was born-virology.

Historically, medical science has vacillated on the question of whether a virus is alive. Originally it was described as nonliving, but is currently said to be an extremely complex molecule or an extremely simple microorganism, and is usually referred to as a parasite having a cycle of life. (The term “killed” is applied to certain viral vaccines, thus implying an official conviction that viruses live.) Commonly composed of either DNA or RNA cores with protein coverings, and having no inherent reproductive ability, viruses depend upon the host for replication. They must utilize the nucleic acids of living cells they infect to reproduce their proteins (i.e., trick the host into producing them), which are then assembled into new viruses like cars on an assembly line. Theoretically, this is their only means of surviving and infecting new cells or hosts.

Click here to read more: http://medcraveonline.com/IJVV/IJVV-02-00032.php

To order your copy of Second Thoughts About Viruses, Vaccines and the HIV/AIDS Hypothesis go to: https://www.amazon.com/…/ref=dbs_a_def_rwt_hsch_vapi_taft_p…

 

Lecture in Dubai – The Annual Conference on Bacterial, Viral and Infectious Diseases

Key Note Speakers in Dubai

Join Robert O Young PhD and Galina Migalko MD in Dubai on December 5th and 6th, 2018 for the Annual Conference on Bacterial, Viral and Infectious Diseases. They will be Key Note Speakers and doing a workshop on the New Biology. To learn more email us at: phmiraclelife@gmail.com or go to: http://www.drrobertyoung.com

The following is the abstract for Dr. Young’s lecture:

The Dismantling of the Viral Theory
Robert O Young CPT, MSc, DSc, PhD, Naturopathic Practitioner

SMLXL

Abstract

There is now over 100 years of documented history and research on the Polio virus and whether or not its treatment by inoculation has been successful in eradicating Polio. I am suggesting in this article and in my lecture that there are significant findings based on historical and past and current research, including my own that the viral theory of Polio and possibly other modern-day diseases, such as Post-Polio Syndrome, Polio Vaccine-Induced Paralysis, Legionnaires, CNS disease, Cancer, HIV/AIDS and now Zika may be caused by acidic chemical poisoning from DDT (dichloro-diphenyl-trichloroethane) and other related DDT pesticides, acidic vaccinations, and other factors including lifestyle and dietary factors rather than from a lone infectious virus. I will present ten historical graphs outlining the history of Polio, the production of DDT, BHC, Lead, Arsenic, Polio vaccinations and the author’s theory that chemical poisoning, vaccination, and lifestyle and dietary choices are a more likely causes for the symptoms of Polio, neurological diseases, Cancer, HIV/AIDS and now Zika.You can also learn more by reading the following published articles:

1) https://www.linkedin.com/…/possible-cause-polio-post-polio…/

2) https://www.linkedin.com/…/dismantling-pasteurs-germ-theor…/

The following is the “Abstract” for Dr. Galina Migalko MD, NMD for the upcoming lecture and workshops at the upcoming conference on December 5th and 6th at the Radisson Hotel in Dubai.

The Importance of Interstitial Fluid Evaluation in Relationship to Any Health Condition

Dr Galina Migalko MD, NMD

Abstract

Due to the many ineffective and incomplete diagnostic and treatment results of conventional medical protocols (e.g. Comprehensive Blood and Chemistry tests,  mammograms,  antibiotics, antivirals, chemotherapy and radiation), more efficient alternative methods are needed. The potential of Non-invasive Medical Diagnostics (NMD) coupled with an Alkaline Lifestyle and Diet (ALD) as a legitimate alternative to  radioactive diagnostice and chemical treatments are examined. While largely ignored in conventional Medicine, the pH and electrolytes of the interstitial fluids of the Interstitum is suggested as an important part in identifying any viral, bacterial, fungal and/or cancerous condition. It is further suggested that all of these conditions may be the result of an over-acidic chemistry of the interstitial fluids of the body that can be prevented or reversed with an alkalizing lifestyle and diet (ALT). Non-invasive Blood Testing (NBT) and Full Body Bio-Electro Interstitial Fluid Scan (FBBIES) are presented as a noninvasive and non-radioactive diagnostic tests to examine the body fluids pH, chemistry, metabolic data and functionality of the organs and organ systems in the presence of any acidic disease causing condition. In addition, non-invasive Full-Body Thermography (FBT) and Full-Body Ultrasound (FBU) combined with the interstitial fluid testing (FBBIES) are presented as noninvasive methods to examine the physiology, the anatomy and the functionality of the organs, organ systems, glands and tissues in relationship to acute or chronic health conditions in the prevention, diagnosis, prognosis, treatment and monitoring the progress of  any therapy progress. Finally, qualitative and quantitative non-invasive Blood Evaluation (NBE) is used as an important part of determining hematological data to compare with the interstitial fluid analysis (FBBIES). In contrast, to the potential chemical acidosis caused by conventional medical treatments, ALT methods such as Intravenous Nutritional Infusion (INI), Rectal Nutritional Infusion (RNI), alkaline foods and drinks, alkaline nutritional supplements, detoxification, exercise and stress reduction provide an alkalizing approach in preventing and reversing any serious health condition.

To register for the Annual Conference on Bacterial, Viral and Infectious Diseases go to:

https://bacterialdiseases.infectiousconferences.com/registration.php

High Cholesterol ‘does not cause heart disease’​

Screen Shot 2018-09-26 at 4.50.38 PM

Cholesterol does not cause heart disease and trying to reduce it with statin drugs is a waste of time, an international group of experts has claimed.

A review of research involving nearly 70,000 people found there was no link between what has traditionally been considered “bad” LDL cholesterol and the premature deaths of over 60-year-olds from cardiovascular disease.

Published in the BMJ Open journal, the new study found that 92 percent of people with a high cholesterol level lived longer. (BMJ Open. Published online June 12 2016)

The authors have called for a re-evaluation of the guidelines for the prevention of cardiovascular disease and atherosclerosis, a hardening and narrowing of the arteries, because “the benefits from statin treatment have been exaggerated”.

High cholesterol is commonly caused by an unhealthy acidic lifestyle and diet, and eating high levels of processed fat in particular, as well as smoking.

It is carried in the blood attached to proteins called lipoproteins and has been traditionally linked to cardiovascular diseases such as coronary heart disease, stroke, peripheral arterial disease and aortic disease.

Co-author of the study Dr Malcolm Kendrick, an intermediate care GP, acknowledged the findings would cause controversy but defended them as “robust” and “thoroughly reviewed”. “What we found in our detailed systematic review was that older people with high LDL (low-density lipoprotein) levels, the so-called “bad” cholesterol, lived longer and had less heart disease.”

 ​

Vascular and endovascular surgery expert Professor Sherif Sultan from the University of Ireland, who also worked on the study, said cholesterol is one of the “most vital” molecules in the body and prevents infection, cancer, muscle pain and other conditions in elderly people. He also stated, “lowering cholesterol with medications is a total waste of time and money”.

“Lowering cholesterol with medications for primary cardiovascular prevention in those aged over 60 is a total waste of time and resources, whereas altering your lifestyle is the single most important way to achieve a good quality of life,” he said.

Lead author Dr Uffe Ravnskov, a former associate professor of renal medicine at Lund University in Sweden, said there was “no reason” to lower high-LDL-cholesterol.

Heart Disease and Cholesterol

The graph below shows the famous 10 year Framingham correlation study between cholesterol and coronary heart disease, published in the Lancet in 1986, that big Pharma relies on and sold to the American public at large.

The problem though, as you see in the next graph, after 20 years the correlation shows that high cholesterol saves lives and low cholesterol is a risk factor for heart disease!​

Everyone in modern society has heard about cholesterol, and how bad it is. Most do not understand why it exists, and simply see it as a menace that must be eliminated as quickly as possible. This misunderstanding is exactly what the pharmaceutical complex promotes, because it allows them to perpetually treat high cholesterol with drugs like Lipitor. These drugs are prescribed for the remainder of a patient’s lifetime, and when he/she eventually dies of a “thought attack”, family and friends will believe that the disaster was inevitable from “high cholesterol”. The death will not be attributed to other health factors or to the drugs themselves, but to the “high cholesterol”; even though there are no known deaths from cholesterol in human history. It is all very convenient for the drug companies, so long as we do not examine what is up the other sleeve.

I am reminded of restless leg syndrome, whereby the dis-ease was ‘discovered’ immediately after the pharmaceutical for it was patented, as a reason to sell us this useless pharmaceutical drug. Now, restless leg syndrome has been upgraded to a new “disease”. The cause of restless leg syndrome is also the cause of heart disease – retained metabolic and/or dietary acids in the connective and fatty tissues leading to inflammation, induration, ulceration, degeneration and finally death

“Before 1920, coronary heart disease was rare in America — so rare that when a young internist named Paul Dudley White introduced the German Electrocardiograph to his colleagues at Harvard University, they advised him to concentrate on a more profitable branch of medicine. The new machine revealed the presence of arterial blockages, thus permitting early diagnosis of coronary heart disease. But in those days, clogged arteries were a medical rarity, and White had to search for patients who could benefit from his new technology. During the next forty years, however, the incidence of coronary heart disease rose dramatically, so much so that by the mid 1950’s, heart disease was the leading cause of death among Americans.”

— Mary Enig, Ph.D.

The amount of cholesterol that you eat actually has very little relationship with the amount that you have in your blood. When you eat more cholesterol, your body produces less, and when you eat less cholesterol, your body produces more. Another way to say this is like this – when you have more metabolic or dietary acid in your blood and interstitial fluids the body produces more LDL cholesterol, and when you have less metabolic or dietary acid in your blood and interstitial fluids the body produces less cholesterol. Why? Because LDL cholesterol is a buffer or chelator of metabolic and/or dietary waste. Understand? A body usually produces between three and four times the cholesterol that one eats. The amount produced is generally related to how much is needed. Cholesterol is indeed needed and critical for optimal health. The purpose of so-called “bad cholesterol” is not to give us heart attacks, but to buffer acidic metabolic and dietary waste and to repair the damage to arteries or veins from our acidic lifestyles and diets.

Whenever a poor acidic diet and lifestyle leads to damaged arteries, a thick and sticky substance is required to patch them. That substance is known as LDL or “bad cholesterol”. When this damaging behavior is continued, multiple patches are created, leading to what we know as “clogged arteries”. The problem is not the cholesterol, which is doing its wonderful job of preventing our death from internal bleeding. The problem is the fact that the arteries or veins are damaged enough from acidic lifestyle and dietary choices to risk internal bleeding. Blocking a body’s healthy countermeasure only leads to worse problems. It is the pharmaceutical standard of symptom suppression that is like hiding the timer of a time bomb, and then expecting it not to eventually go off. Thus, that so-called “BAD” cholesterol is not “BAD” at all. In fact LDL cholesterol is saving your acidic body from internal bleeding and inevitable death. LDL cholesterol ONLY increases in the presence of excess metabolic, dietary, respiratory and/or environmental acids which increase as a result of what you eat, what you drink and what you think. High LDL cholesterol is a warning sign of your poor acidic lifestyle and dietary choices and the body is in preservation mode. It is trying to protect itself from YOU!

Cholesterol is created to save your life! The following picture is what solidified metabolic acid bound cholesterol looks like in the blood.

Modern medicine spends a lot of time fighting this pitch, instead of the actual causes of arterial damage. Thus, it is not surprising that cholesterol-lowering drugs cause more heart dis-ease and more heart attacks and strokes. A massive portion of the elderly population is taking cholesterol-lowering drugs, even though research shows that the higher their cholesterol levels (especially LDL) the longer that they will live and the less risk for a heart attack or stroke. The graph below illustrates this point! Low cholesterol in the elderly is actually a sign that something is seriously wrong, and a heart attack or stroke may be imminent. Modern medicine has only recently come to accept that at least some cholesterol (LDL and HDL) is good and protective! But when you mention (LDL) cholesterol as “GOOD” you better take cover from current medical savants who will attack you with their ignorance!

Cholesterol is still suppressed with drugs, despite what science would make prudent from the long-term Framingham Study. It also has been proven that these drugs cause high suicide rates. The drugs can lead to personality changes, in a manner similar to (but not as intense as) S.S.R.I. antidepressants.

The anti-cholesterol hysteria began in the 1950’s, when researcher Ancel Keys proposed the Lipid Hypothesis. It stated that cholesterol and saturated fats lead to heart disease. His beliefs were promoted heavily by the new hydrogenated oils industry, which spent obscene amounts of money to convince every one of Keys’ indisputable findings. This successful marketing campaign was on par with similar marketing for fluoride at about the same time. Studies which had oppositional findings to Keys’ were ignored or maligned. As a result of his flawed scientific methodology (subjective cherry picking results to match what he wanted to find) saturated fats like butter and eggs were used less, in exchange for the poisonous trans-fats that are in hydrogenated oils. Heart disease rates have been rising exponentially ever-since.

The French eat more fats than any other group in the world, yet they have lower rates of heart disease. The Japanese eat more fats than Americans, yet have lower rates of heart disease. There are plenty of countries with similar patterns. The French lifestyle especially counters Keys’ hypothesis, and it also provides evidence that resveratrol (found in red or purple grapes) improves heart health. Resveratrol has been shown to reverse atherosclerosis (hardening of the arteries). Maybe, just maybe its being American that causes higher rates in heart attacks.   The bottom-line medical research is subjective NOT objective!​

Just recently the Food and Drug Administration issued new safety warnings about a popular class of drugs used to control and lower cholesterol levels. The FDA says the drugs, known as statins, can cause several side effects, including cognitive problems such as memory lapses and confusion. But the agency is stressing that the side effects appear to be rare and not serious. I have suggested that taking any drug, like statin drugs that lowers LDL cholesterol without removing acidic lifestyle and dietary choices is a risk for heart attack, stroke and other dis-eases like diabetes. I have lowered cholesterol successfully in all cases of hyper-chlolesterolemia without drugs by just changing the diet and lifestyle to an alkaline pH Miracle lifestyle and diet that restores the alkaline design of the body.

One of my research clients Maren Hale was diagnosed with familial hypercholesterolemia and hyper-triglycerides with LDL’s over 400 mg/dl and triglycerides over 200 mg/dl. She was also overweight. Over a period of four years Maren lost over 70 pounds and lowered her cholesterol and triglycerides to healthy normal ranges on the pH Miracle Lifestyle and Diet. Maren and her family and extended family have been a research study of the University of Utah for familial hypercholesterolemia for over 60 years. Maren was the first of all family members to lower her cholesterol and triglycerides to normal ranges due to her commitment to living a pH Miracle Lifestyle and Diet.​

High cholesterol levels should be a warning to most people who inflammation caused by metabolic and dietary acid is present. It is a risk marker, and a symptom that can save your life! Eliminating the LDL cholesterol through drugs is the equivalent to eliminating the thermometer in a room that is too hot. It is illogical, and it does nothing to eliminate the dangerous cause of the symptom being expressed.

LDL cholesterol levels naturally drop whenever the body’s becomes less acidic and more alkaline in the interstitial fluids where acids are stored! And LDL cholesterol should never be forced lower with drugs because they WILL cause a heart attack or stroke! The pH Miracle alkaline lifestyle and diet can reduce LDL cholesterol, but it is never because of a lowered cholesterol intake.

The natural drop in cholesterol and triglycerides happens only when a person stops eating toxic acidic foods, drinking toxic acidic drinks and stops toxic acidic thoughts that produce toxic acidic waste products that destroy the arteries and veins!

Do YOU Understand?

Because healthy arteries and veins do not need patching. Remember that a body typically produces 3-4 times the amount of LDL cholesterol than consumed. The fats that a person eats are therefore comparatively insignificant. Cholesterol will rise whenever the body’s need for cholesterol rises and in direct relationship to the level of acidic thoughts, words and deeds. So acidic trans-fats and inflammatory acidic substances are what need to be avoided. These toxic acidic wastes are what damage the arteries and veins, and a body will be required to do a great deal of patching as a consequence. I will reference to alkalizing or chelating herbs and minerals that lower cholesterol levels naturally later, but alkalizing and chelating herbs and minerals do it by lowering the body’s need for LDL cholesterol, not by forcefully lowering it like pharmaceuticals do.

Studies on the link between cholesterol and heart health have been manipulated for decades. The first studies on eggs showed elevated cholesterol levels because they had used dehydrated eggs, and studies of coconut oil yielded similar results because they had used partially hydrogenated coconut oil to get the results that they wanted. That is why I state that ALL scientific research is subjective NOT objective!!!!!!!!!!!!!!!!!!!!!! Read about it here: http://wp.me/p5ggLY-a5

It is Simple – Cholesterol DOES NOT CAUSE Heart Disease!

Simply stated, without acid caused inflammation being present in the body, there is no way that cholesterol would accumulate on and in the wall of the blood vessel and cause heart disease and strokes. Without acid caused inflammation, cholesterol would move freely throughout the body as nature intended. It is acid caused inflammation from acidic lifestyle and dietary choices that causes cholesterol to become trapped.

Acid caused inflammation is not complicated. The cycle of metabolic and dietary acid inflammation is perfect in how the body releases cholesterol to bind acids that cause inflammation in the first place. However, if we chronically expose the body to injury to acidic poisonous toxins from acidic foods and drinks the human body was never designed to process, a condition occurs called systemic latent tissue acidosis that is the cause of ALL inflammation. Chronic acidic inflammation is just as harmful as acute acidic inflammation and are both caused by an increase of dietary and metabolic acids.

What thoughtful person would willfully expose himself or herself repeatedly to acidic foods, drinks, drugs or other substances that are known to cause injury to the body? Well, smokers, alcohol, coffee black tea, soda pop, energy and sport beverage drinkers perhaps, but at least they made that choice willfully.

The rest of us have simply followed the recommended mainstream acidic diet that is low in polyunsaturated fats, high in acidic carbohydrates and highly acidic animal flesh, not knowing we were causing repeated acidic injury to our blood vessels. This repeated injury creates chronic acidic inflammation leading to heart disease, stroke, diabetes and obesity.​

Let me repeat: The injury and inflammation caused from acidic foods, drinks and metabolism in our blood vessels is the cause of stokes, heart attacks, diabetes and obesity and NOT the increase of cholesterol. A low healthy fat and salt diet recommended for years by mainstream medicine will cause strokes, heart attacks, diabetes and obesity.
What are the biggest culprits of chronic acidic inflammation? Quite simply, they are the overload of simple, highly processed carbohydrates (sugar, dairy products, animal flesh, chocolate, coffee, tea, including green tea, alcohol, soda pops, vinegar, peanuts, mushrooms, flour and corn and all the products made from them) and the excess consumption of saturated vegetable oils like soybean, corn and sunflower that are found in many processed foods.

Take a moment to visualize rubbing a stiff brush repeatedly over soft skin until it becomes quite red and nearly bleeding if you kept this up several times a day, every day for five years. If you could tolerate this painful brushing, you would have a bleeding, swollen infected area that became worse with each repeated acid causing injury. This is a good way to visualize dietary and metabolic acids as the brush leading to the inflammatory process that could be going on in your body right now.

Regardless of where the acidic inflammatory process occurs, externally or internally, it is the same. Using Ultrasound I have peered inside thousands upon thousands of arteries. A diseased artery looks as if someone took a brush and scrubbed repeatedly against its wall. Several times a day, every day, the acidic foods we eat create small injuries compounding into more injuries, causing the body to respond continuously and appropriately with increased acid caused inflammation.

While we savor the tantalizing taste of a sweet roll, chocolate or a carbonated drink our body responds alarmingly as if a foreign invader arrived declaring war. ACIDIC foods loaded with sugars and simple carbohydrates, or processed with saturated oils for long shelf life have been the mainstay of the American diet for six decades. These acidic foods have been slowly poisoning everyone.

How does eating a simple sweet roll or a piece a chocolate create a cascade of acid causing inflammation to make you sick?

Imagine spilling acidic sugary syrup on your keyboard and you have a visual of what occurs inside the cell. When we consume simple carbohydrates such as sugar, blood sugar rises rapidly. In response, your pancreas secretes insulin and sodium bicarbonate whose primary purpose is to bind and solidify acids so they do NOT destroy healthy body and blood cells and cause internal bleeding. In addition, the body releases cholesterol to help solidify excess dietary and/or metabolic acids that have NOT been properly eliminated through the four channels of elimination – urination, perspiration, respiration and defecation.​

The body solidifies acids to protect healthy tissues, glands and organs from ulceration and then degeneration. After years of an acidic lifestyle and diet solidified acids will build-up on the wall of the arteries and veins leading to atherosclerosis, stroke and heart attack.

What does all this have to do with inflammation? Blood sugar which is a metabolic acid is controlled in a very narrow range. Extra acidic sugar molecules that are not solidified and eliminated through the four channels of elimination will injure the blood vessel wall. This repeated acidic injury to the blood vessel wall causes irritation, inflammation, ulceration and eventual degeneration or heart disease and/or cancer. When you spike your blood sugar levels or acid levels several times a day, every day, with acidic foods or thoughts it is exactly like taking sandpaper to the inside of your delicate blood vessels.

While you may not be able to see it, rest assured, tissue, gland and organ acidosis is present. I have seen it in over 40,000 client/patients spanning over 30 years who all shared one common denominator — dietary and metabolic acid caused inflammation in their veins, arteries, glands, tissues and organs. This is what retained physiological acid looks like in the tissues using full-body thermography to show the acidic red and white hot spots.

Let’s get back to the sweet roll and chocolate. These innocent looking goodies not only contain the acid sugar, they are also fermented and processed in one of many saturated oils. Chips and fries are soaked in soybean oil; processed foods are manufactured with saturated oils for longer shelf life.

If the balance shifts by consuming excessive sugar, animal protein, vinegar, coffee, tea, alcohol, corn, peanuts and saturated oil, the cell membranes will be damaged and the body and blood cells will begin to degenerate causing even more acids leading to greater risk of inflammation and dis-ease.

Today’s mainstream American ACIDIC diet has produced an extreme imbalance in the alkaline design of the body and an increase in dietary and metabolic acids that cause ALL sickness and dis-ease. You read this correctly – ALL sickness and dis-ease is caused by metabolic, dietary, respiratory and/or environmental ADIDS! There are no other causes. Germs and viruses are the symptoms of cellular breakdown and NOT the cause of ANY disease. Simply said, germs do NOT cause dis-ease!

To make matters worse, eating these acidic foods and drinks causes the body to hold on to more fat as a depository for these excess acids that are NOT being properly eliminated through the four channels of elimination. That is why people get fat. The increase in fat is in direct relationship to the increase of acidic foods, drinks and lifestyle choices. The process that began with a sweet roll or a cup of coffee, or a piece of chocolate or a glass of wine turns into a vicious cycle over time that creates heart disease, stroke, high blood pressure, diabetes, obesity and finally, Alzheimer’s disease, as the acid caused inflammatory process continues unabated.
There is no escaping the fact that the more we consume prepared and processed acidic foods, the more we increase the inflammation switch little by little each day. The human body cannot process, nor was it designed to consume, foods packed with sugars, animal flesh, dairy products, vinegar, alcohol, coffee, tea, chocolate, soda pop, mushrooms, peanuts, corn, flour and saturated processed oils.

There is but one answer to quieting acid caused inflammation, and that is returning to foods closer to their natural alkaline state. To build muscle, eat more chlorophyll concentrated alkaline foods.

Choose carbohydrates that are very complex such as colorful fruit and vegetables. Cut out of your diet saturated oils from corn or soybean.

One tablespoon of corn oil contains 7,280 mg of saturated oil; soybean contains 6,940 mg. Instead, use olive oil, avocado oil, hemp oil or fax oil.

Forget the “science” that has been drummed into your head for decades. The science that saturated fat alone causes heart disease is non-existent. The science that saturated fat raises blood cholesterol is also very weak. Since we now know that cholesterol is not the cause of heart disease, the concern about saturated fat having no place on its hydrogen chain to buffer metabolic and dietary acid is real science. It is acid that causes disease and ALL polyunsaturated oils help to buffer excess acids by the carbon chain picking up the hydrogen ion or acid on its unsaturation. In other words, all polyunsaturated fats whether Omega 1, 3, 6 or 9 buffer or neutralize all dietary and/or metabolic acids on their unsaturated carbon.

The cholesterol theory led to the no-fat, low-fat recommendations that in turn created the very acidic foods now causing an epidemic of acid caused inflammation,induration, ulceration and degeneration. Mainstream medicine made a terrible mistake when it advised people to avoid foods high in cholesterol. We now have an epidemic of arterial acidic caused inflammation leading to heart disease and other silent killers.

Government nutrition guidelines recommend a diet high in carbohydrate regardless of the ample evidence of the health risks it promotes. Yet, heart disease and obesity rates have risen in correlation with a reduced intake of dietary fat. The Food Standards Agency states all individuals’ diets should contain “plenty of starchy foods such as rice, bread, pasta and potatoes”. In addition to this, “just a little saturated fat”. This recommendation is a recipe for heart disease and stroke because of its high level of dietary acid.

While science has moved on, nutritional advice lags behind. And in a study published in Open Heart, a group of researchers conclude that national dietary advice on fat consumption issued to millions in the 1970s to reduce the risk of heart disease which suggested that fat should form no more than 30% of daily food intake lacked any solid trial evidence and shouldn’t have been introduced.

While more circumspect, cardiologist Rahul Bahl wrote in a linked editorial:

“There is certainly a strong argument that an over-reliance in public health on saturated fat as the main dietary villain for cardiovascular disease has distracted from the risks posed by other nutrients, such as carbohydrates.”

Fat and High-Carbohydrate Foods

Some fats aren’t good – trans fats, for example, which are mostly man-made – while others, such as monounsaturated fats found in olive oil are seen as having beneficial qualities.

Today, government guidelines recommend that fats should compose no more than 35% of an individual’s daily calorie intake – and that saturated fat, in particular, ought to supply less than 11%.

Fat intake decreased from 36.6% to 33.7% from 1971 to 2006, while the intake of carbohydrates rose from 44.0% to 48.7%. Yet obesity levels have escalated.

There is evidence to also show that carbohydrates can lead to feelings of increased hunger. A recent study in The American Journal of Clinical Nutrition found that eating carbohydrate foods with a high glycemic index (bread, rice, pasta) caused effects on the brain that led to feelings of increased hunger, which could in turn lead to eating more.​

Another study in 2013 found high-carb meals could leave you feeling hungrier hours later compared to a low-carb meal with more fibre, protein and fat. The team behind the research attributed this to the plummeting levels of blood sugar that regularly follows high-carb meals.

The Diet-Heart Hypothesis

At the University of Hull they have been also looking at the effects of saturated fats on triglyceride levels – a type of fat (lipid) found in the blood. Using coconut oil because of its high (90%) saturated fat content, we found that when coupled with exercise, it significantly reduced triglyceride levels. A recent Brazilian rat study also found that coconut oil and exercise could lower blood pressure.

So where does our unshakable idea that fat leads to heart disease come from? The diet-heart hypothesis, that low density lipoproteins (LDL) cholesterol is raised in the blood by eating saturated fat, which then leads to clogged arteries and eventual heart disease, is not a credible claim.

This theory linking saturated fat and heart disease has been around since 1955 when Ansel Keys introduced his lipid hypothesis. Despite it being the foundation of dietary recommendations, it has never been proven and we have been advised to avoid certain foods including meat, dairy products and coconuts. And these myths are so deeply embedded in our minds, that recent science advocates have seen how hard it is to challenge established thinking.

Saturated Fat and Cholesterol

When we talk about high-density lipoprotein (HDL) or LDL – often referred to as good and bad cholesterol – we aren’t actually referring to cholesterol itself. These lipoproteins actually carry cholesterol, fat and fat soluble vitamins in the bloodstream. It appears that elevated levels of cholesterol (or more accurately, cholesterol which is transported around the blood by lipioproteins) is correlated with an increase in the risk of heart disease.

However, correlation does not mean causation. Very low cholesterol is linked with an increased risk of death (though not from heart disease). And in the very old, research suggests cholesterol can be protective. So it’s fair to say the relationship between cardiovascular disease and total cholesterol is complex.

Type of cholesterol is important. The “good” (HDL) cholesterol is strongly linked with a reduced risk of heart disease. However, LDL, the “bad” cholesterol, is associated with an increased risk of heart disease. But it turns out that there are in fact subtypes of LDL which make this black and white picture more complicated. The actual size of the LDL particle is significant. Individuals are at a heightened risk of heart disease if they have most small, dense LDL particles, that may more easily lodge in the arteries, as opposed to those who have large LDL particles.

Your blood lipid profile is frequently used as a medical screening tool for abnormalities in lipids (including triglycerides and cholesterol). These blood lipid profile tests can identify approximate risks for cardiovascular disease and specific genetic diseases. Studies have also shown that saturated fats do not harm your blood lipid profile – and can actually improve it. Saturated fats could lower the risk of heart disease by shifting LDL cholesterol from dense small LDL to large LDL.

Numerous short-term feeding trials have shown that an increase in saturated fat consumption leads to a rise in overall LDL. Nevertheless, the result is inconsistent and weak. The methods used in a number of these research studies have been criticised – and plenty of studies support the contrary, that no association exists between total LDL and saturated fat consumption.

Cause and Correlation

If it was true that saturated fat did cause heart disease, then it follows that people who consume more would be at higher risk. But observational studies – again only illustrative of correlation not cause – haven’t shown this. One study looked at a population of 347,747 subjects from a total of 21 studies and concluded that there was “no significant evidence for concluding that dietary saturated fat is associated with an increased risk of coronary heart or cardiovascular disease”. This has also been the conclusion of other reviews.

So What About Randomized Controlled Trials?

One such study divided 12,866 male subjects at a high risk of heart disease into a low-fat or Western diet group. After six years, no difference was found between them. The Women’s Health Imitative, the biggest randomized controlled trial in diet history, comprised of 48,835 postmenopausal women who were also divided into two similar groups and came up with similar findings.

The Cold-Pressed Organic Coconut Oil Connection

If you don’t care for the science, then take an everyday example. Look at the large populations of the Masai in Africa who consume large amounts of saturated fat but have low levels of coronary heart disease. Or the Tokelauans of New Zealand who consume a massive amount of saturated fat through coconuts: more than 60% of their daily calories come from coconuts. These populations have no history of heart disease. And the health benefits of coconut oil are now becoming known more widely.

We are learning so much more about fats and that there is no evidence that saturated fat causes heart disease. Leading nutrition experts have been calling for an amendment to dietary recommendations for more than ten years. But despite these calls and the high-quality evidence assembled throughout the past decade, doctors, governments – and by extension the public – still take extraordinarily little notice. But a decade of research to the contrary would suggest it’s time we moved away from entrenched thinking, towards a more enlightened attitude to saturated fat.
What you can do is choose whole, organic, raw, NON-GMO, alkaline foods your grandmother served and not those your mom turned to as grocery store aisles filled with manufactured acidic foods and drinks. By eliminating acidic causing inflammatory foods and adding essential nutrients from fresh, raw, organic, alkaline unprocessed food, you will reverse years of damage in your arteries and throughout your body from consuming the typical American ACIDIC diet.

To learn more read the following article, THE PH MIRACLE FOR HEART DISEASE – DISCOVER THE TRUTH ABOUT HEART DISEASE, CONGESTIVE HEART FAILURE, ATHEROSCLEROSIS, CHOLESTEROL, HYPERTENSION, STROKE AND MORE! –

https://phoreveryoung.wordpress.com/2015/08/06/a-self-care-to-a-self-cure-for-heart-disease-a-number-1-killer/​

References

  1. Ravnskov U, Diamond DM, Hama R, et al. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review
  2. Office Of Dietary Supplements Fact Sheet: Folate
  3. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellos J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine. Circulation. 2002;105:22-6.
  4. Doshi SN, McDowell IFW, Moat SJ, Lang D, Newcombe RG, Kredean MB, Lewis MJ, Goodfellow J. Folate improves endothelial function in coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:1196-1202.
  5. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J, Scott J. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001;161:695-700.
  6. Jennings E. Folic acid as a cancer preventing agent. Med Hypothesis 1995;45:297-303.
  7. Freudenheim JL, Grahm S, Marshall JR, Haughey BP, Cholewinski S, Wilkinson G. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991;20:368-74.
  8. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE, Willett WC. Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med 1998;129:517-24.
  9. A Paoloni-Giacobino, R Grimble, C Pichard. Genetics and nutrition. Clinical Nutrition Volume 22, Issue 5, Pages 429-435 (October 2003)
  10. Corradaa MM, Kawasab CH, Hallfrischc J, Mullerd D, Brookmeyere R. Reduced risk of Alzheimer?s disease with high folate intake: The Baltimore Longitudinal Study of Aging. Alzheimer’s and Dementia Volume 1, Issue 1, Pages 11-18 (July 2005).
  11. Wang HX, Wahlin Å, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B12 and folate in relation to the development of Alzheimer?s disease. Neurology May 8, 2001 vol. 56 no. 9 1188-1194.
  12. Office Of Dietary Supplements Fact Sheet
  13. Appel LJ. Nonpharmacologic therapies that reduce blood pressure: A fresh perspective. Clin Cardiol 1999;22:1111-5.
  14. Simopoulos AP. The nutritional aspects of hypertension. Compr Ther 1999;25:95-100.
  15. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-24.
  16. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium: an update on physiological, clinical, and analytical aspects. Clinica Chimica Acta 2000;294:1-26.
  17. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. National Academy Press. Washington, DC, 1999.
  18. Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio H, D’Onofrio F. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992;55:1161-7.
  19. Altura BM and Altura BT. Magnesium and cardiovascular biology: An important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 1995;41:347-59.
  20. Ford ES. Serum magnesium and ischaemic heart disease: Findings from a national sample of US adults. Intl J of Epidem 1999;28:645-51.
  21. Liao F, Folsom A, Brancati F. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998;136:480-90.
  22. Ascherio A, Rimm EB, Hernan MA, Giovannucci EL, Kawachi I, Stampfer MJ, Willett WC. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 1998;98:1198-204.
  23. Elisaf M, Milionis H, Siamopoulos K. Hypomagnesemic hypokalemia and hypocalcemia: Clinical and laboratory characteristics. Mineral Electrolyte Metab 1997;23:105-12.
  24. Xing JH and Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 2001;44:1201-9.
  25. Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998;5(1):24-27.
  26. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257-263.
  27. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine–a double-blind placebo-controlled study. Cephalalgia. 1996;16(6):436-440.
  28. Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003;43(6):601-610.
  29. Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J Am Coll Nutr. 2000;19(1):3-12.
  30. Rude RK. Magnesium deficiency: A cause of heterogeneous disease in humans. J Bone Miner Res 1998;13:749-58.
  31. Rude KR. Magnesium metabolism and deficiency. Endocrinol Metab Clin North Am 1993;22:377-95.
  32. Kelepouris E and Agus ZS. Hypomagnesemia: Renal magnesium handling. Semin Nephrol 1998;18:58-73.
  33. Ramsay LE, Yeo WW, Jackson PR. Metabolic effects of diuretics. Cardiology 1994;84 Suppl 2:48-56.
  34. Kobrin SM and Goldfarb S. Magnesium Deficiency. Semin Nephrol 1990;10:525-35.
  35. Lajer H and Daugaard G. Cisplatin and hypomagnesemia. Ca Treat Rev 1999;25:47-58.
  36. Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 1996;156:1143-8.
  37. Paolisso G, Scheen A, D’Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia 1990;33:511-4.
  38. Elisaf M, Bairaktari E, Kalaitzidis R, Siamopoulos K. Hypomagnesemia in alcoholic patients. Alcohol Clin Exp Res 1998;22:244-6.
  39. Abbott L, Nadler J, Rude RK. Magnesium deficiency in alcoholism: Possible contribution to osteoporosis and cardiovascular disease in alcoholics. Alcohol Clin Exp Res 1994;18:1076-82.
  40. Rude RK, Shils ME. Magnesium. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, eds. Modern Nutrition in Health and Disease. 10th ed. Baltimore: Lippincott Williams & Wilkins; 2006:223-247.
  41. Food and Nutrition Board, Institute of Medicine. Magnesium. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington D.C.: National Academy Press; 1997:190-249.
  42. Schwartz R, Walker G, Linz MD, MacKellar I. Metabolic responses of adolescent boys to two levels of dietary magnesium and protein. I. Magnesium and nitrogen retention. Am J Clin Nutr. 1973;26(5):510-518.
  43. Shils ME. Magnesium. In Modern Nutrition in Health and Disease, 9th Edition. (edited by Shils, ME, Olson, JA, Shike, M, and Ross, AC.) New York: Lippincott Williams and Wilkins, 1999, p. 169-92.
  44. Spencer H, Norris C, Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man. J Am Coll Nutr. 1994;13(5):479-484.
  45. Torsten Bohn, Lena Davidsson*, Thomas Walczyk and Richard F. Hurrel Fractional magnesium absorption is signi?cantly lower in human subjects from a meal served with an oxalate-rich vegetable, spinach, as compared with a meal served with kale, a vegetable with a low oxalate content. Laboratory for Human Nutrition, Institute of Food Science and Nutrition, Swiss Federal Institute of Technology, Zurich, Switzerland (Received 27 May 2003 – Revised 7 November 2003 – Accepted 28 November 2003
  46. FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs)
  47. Leach RM, Harris ED. Manganese. In: O’Dell BL, Sunde RA, eds. Handbook of nutritionally essential minerals. New York: Marcel Dekker, Inc; 1997:335-355.
  48. Freeland-Graves J, Llanes C. Models to study manganese deficiency. In: Klimis-Tavantzis DL, ed. Manganese in health and disease. Boca Raton: CRC Press, Inc; 1994.
  49. Reginster JY, Strause LG, Saltman P, Franchimont P. Trace elements and postmenopausal osteoporosis: a preliminary study of decreased serum manganese. Med Sci Res. 1988;16:337-338.
  50. Odabasi E, Turan M, Aydin A, Akay C, Kutlu M. Magnesium, zinc, copper, manganese, and selenium levels in postmenopausal women with osteoporosis. Can magnesium play a key role in osteoporosis? Ann Acad Med Singapore. 2008;37(7):564-567.
  51. Keen CL, Zidenberg-Cherr S. Manganese. In: Ziegler EE, Filer LJ, eds. Present Knowledge in Nutrition. 7th ed. Washington D.C.: ILSI Press; 1996:334-343.
  52. Carl GF, Gallagher BB. Manganese and epilepsy. In: Klimis-Tavantzis DL, ed. Manganese in health and disease. Boca Raton: CRC Press, Inc; 1994:133-157.
  53. Blaurock-Busch, E. Wichtige Nahrstoffe fur Gesunde Haut und Haare, Kosmetik Internat. 3/87.
  54. Collipp, P.J., et al. Manganese in infant formulas and learning disability. Ann. Nutr. Metab. 27(6):488-494, 1983.
  55. “Guidelines for Niacin Therapy For the Treatment of Elevated Lipoprotein a (Lpa)”. Rush Hemophilia & Thrombophilia Center. August 15, 2002, Revised July 27, 2005. Retrieved 20 November 2009. “facial flushing is a common side effect of niacin therapy that usually subsides after several weeks of consistent niacin use”
  56. Katzung, Bertram G. (2006). Basic and clinical pharmacology. New York: McGraw-Hill Medical Publishing Division. ISBN 0071451536.
  57. Greenbaum CJ, Kahn SE, Palmer JP. Nicotinamide’s effects on glucose metabolism in subjects at risk for IDDM. Diabetes. 1996;45(11):1631-1634.
  58. Lampeter EF, Klinghammer A, Scherbaum WA, et al. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes. 1998;47(6):980-984.
  59. Hageman GJ, Stierum RH. Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mutat Res. 2001;475(1-2):45-56.
  60. Jacobson EL, Shieh WM, Huang AC. Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis. Mol Cell Biochem. 1999;193(1-2):69-74.
  61. Weitberg AB. Effect of nicotinic acid supplementation in vivo on oxygen radical-induced genetic damage in human lymphocytes. Mutat Res. 1989;216(4):197-201.
  62. Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol. 1996;143(12):1244-1256.
  63. Brown RR, Ozaki Y, Datta SP, Borden EC, Sondel PM, Malone DG. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv Exp Med Biol. 1991;294:425-435.
  64. Murray MF, Langan M, MacGregor RR. Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide. Nutrition. 2001;17(7-8):654-656.
  65. Office of Dietary Supplements Fact Sheet: Vitamin B6
  66. New SA, Bolton-Smith C, Grubb DA, Reid DM. Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr. 1997;65(6):1831-1839.
  67. New SA, Robins SP, Campbell MK, et al. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr. 2000;71(1):142-151.
  68. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. 1999;69(4):727-736.
  69. Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation. 1998;98(12):1198-1204.
  70. Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999;30(9):1772-1779.
  71. Fang J, Madhavan S, Alderman MH. Dietary potassium intake and stroke mortality. Stroke. 2000;31(7):1532-1537.
  72. Bazzano LA, He J, Ogden LG, et al. Dietary potassium intake and risk of stroke in US men and women: National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke. 2001;32(7):1473-1480.
  73. Green DM, Ropper AH, Kronmal RA, Psaty BM, Burke GL. Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology. 2002;59(3):314-320.
  74. Barri YM, Wingo CS. The effects of potassium depletion and supplementation on blood pressure: a clinical review. Am J Med Sci. 1997;314(1):37-40.
  75. Hajjar IM, Grim CE, George V, Kotchen TA. Impact of diet on blood pressure and age-related changes in blood pressure in the US population: analysis of NHANES III. Arch Intern Med. 2001;161(4):589-593.
  76. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336(16):1117-1124.
  77. Gennari FJ. Hypokalemia. N Engl J Med. 1998;339(7):451-458.
  78. Shearer MJ. The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Soc. 1997;56(3):915-937.
  79. Booth SL. Skeletal functions of vitamin K-dependent proteins: not just for clotting anymore. Nutr Rev. 1997;55(7):282-284.
  80. Suttie JW. Vitamin K. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, eds. Modern Nutrition in Health and Disease. 10th ed. Baltimore: Lippincott Williams & Wilkins; 2006:412-425.
  81. Allison (2001). The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease. Medical hypotheses 57 (2): 151?5. doi:10.1054/mehy.2001.1307. PMID 11461163.
  82. ODS Fact Sheet on Coumadin – http://ods.od.nih.gov/pubs/factsheets/coumadin1.pdf
  83. Office of Dietary Suppliments Face Sheet: Vitamin C
  84. Gokce N, Keaney JF, Jr., Frei B, et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1999;99(25):3234-3240.
  85. Audera, C (2001). “Mega-dose vitamin C in treatment of the common cold: a randomised controlled trial”. Medical Journal of Australia 389: 175.
  86. Hemilä, Harri; Chalker, Elizabeth; Douglas, Bob; Hemilä, Harri (2007). “Vitamin C for preventing and treating the common cold”. Cochrane database of systematic reviews (Online) (3): CD000980.
  87. Fleming DJ, Tucker KL, Jacques PF, Dallal GE, Wilson PW, Wood RJ (December 2002). “Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort”.
  88. The American Journal of Clinical Nutrition 76 (6): 1375?84.Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000.
  89. Weinstein M, Babyn P, Zlotkin S. An orange a day keeps the doctor away: scurvy in the year 2000. Pediatrics 2001;108:E55.
  90. Hoffman FA. Micronutrient requirements of cancer patients. Cancer. 1985;55 (1 Suppl):295-300.
  91. Deicher R, Hörl WH. Vitamin C in chronic kidney disease and hemodialysis patients. Kidney Blood Press Res 2003;26:100-6. 
  92. Aishah Al-Jarallah, Fatima Igdoura, Yi Zhang, Christine B Tenedero, Elizabeth J White, Melissa E Macdonald, Suleiman A Igdoura, Bernardo L Trigatti. The effect of pomegranate extract on coronary artery atherosclerosis in SR-BI/APOE double knockout mice. Atherosclerosis. 2013 May ;228(1):80-9. Epub 2013 Mar 7. PMID: 23528829
  93. Michael Aviram, Mira Rosenblat, Diana Gaitini, Samy Nitecki, Aaron Hoffman, Leslie Dornfeld, Nina Volkova, Dita Presser, Judith Attias, Harley Liker, Tony Hayek. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr. 2004 Jun;23(3):423-33. PMID: 15158307
  94. GreenMedInfo.com, Pomegranate’s Anti-Inflammatory Properties
  95. Mahalaxmi Mohan, Harshal Waghulde, Sanjay Kasture. Effect of pomegranate juice on Angiotensin II-induced hypertension in diabetic Wistar rats. Phytother Res. 2009 Dec 17. PMID: 20020514
  96. Filomena de Nigris, Maria Luisa Balestrieri, Sharon Williams-Ignarro, Francesco P D’Armiento, Carmela Fiorito, Louis J Ignarro, Claudio Napoli. The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide. 2007 Aug ;17(1):50-4. Epub 2007 May 5. PMID: 17553710
  97. Filomena de Nigris, Sharon Williams-Ignarro, Vincenzo Sica, Lilach O Lerman, Francesco P D’Armiento, Russell E Byrns, Amelia Casamassimi, Daniela Carpentiero, Concetta Schiano, Daigo Sumi, Carmela Fiorito, Louis J Ignarro, Claudio Napoli. Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. Cardiovasc Res. 2007 Jan 15;73(2):414-23. Epub 2006 Sep 1. PMID: 17014835
  98. Yasunori Sawayama, Kyoko Okada, Shinji Maeda, Hachiro Ohnishi, Norihiro Furusyo, Jun Hayashi. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy. Fukuoka Igaku Zasshi. 2006 Aug;97(8):245-55. PMID: 17087362
  99. M Aviram, L Dornfeld, M Rosenblat, N Volkova, M Kaplan, R Coleman, T Hayek, D Presser, B Fuhrman. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000 May ;71(5):1062-76. PMID: 10799367
  100. Adde FV, Rodrizues JC, Cardoso AL. Nutritional follow-up of cystic fibrosis patients: the role of nutrition education. J Pediatr (Rio J). 2004;80(6):475-82.
  101. Beckles Willson N, Elliot TM, Everard ML. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev. 2002;(3):CD002201.
  102. Bope. Conn’s Current Therapy 2010. 1st ed. Philadelphia, PA: Saunders, An Imprint of Elsevier; 2009.
  103. Bruzzese E, Raia V, Gaudiello G, et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther. 2004;20(7):813-9.
  104. Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea — a review. J Am Coll Nutr. 2006;25(2):79-99.
  105. Campbell, T.M. The China Study, BenBella Books; First Paperback Edition edition (May 11, 2006).
  106. Caramia G, Cocchi M, Garliardini R, et al. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture. Pediatr Med Chir. 2003;25(1):42-9.
  107. Chin J. Intestinal microflora: negotiating health outcomes with the warring community within us. Asia Pac J Clin Nutr. 2004;13(Suppl):S24-5.
  108. Cvetnic Z, Vladimir-Knezevic S. Antimicrobial activity of grapefruit seed and pulp ethanolic extract. Acta Pharm. 2004;54(3):243-50.
  109. D’Agostino, Russell MW, Huse DM et al. ‘Primary and subsequent coronary risk appraisal: new results from the Framingham Study’, American Heart Journal 2000.
  110. D’Agostino, Russell MW, Huse DM et al. ‘Primary and subsequent coronary risk appraisal: new results from the Framingham Study’, American Heart Journal 2000.
  111. D’Agostino, Vasan, Pencina, Wolf, Cobain, Massaro, Kannel. ‘A General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study’.
  112. D’Agostino, Wolf, Belanger, Kannel ‘Stroke Risk Profile: Adjustment for Antihypertensive Medication’, Stroke 1994.
  113. Dolinoy D.C., Weidman J.R., Waterland R.A., Jirtle R.L. (2006). Maternal Genistein Alters Coat Color and Protects Avy Mouse Offspring from Obesity by Modifying the Fetal Epigenome. Environmental Health Perspectives, 114:567-572.
  114. Dolinoy D.C., Huang D., Jirtle R.L. (2007). Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. PNAS, 104: 13056-13061.
  115. Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther. 2006;4(2):261-75.
  116. Farrell P, Rosenstein B, White T, et al. Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report. Journal of Pediatrics. 2008;153(2)
  117. Ferri. Ferri’s Clinical Advisior 2010. 1st ed. Philadelphia, PA: Mosby, An Imprint of Elsevier; 2009.
  118. Gonclaves C, Dinis T, Batista MT. Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: a mechanism for anti-inflammatory activity. Phytochemistry. 2005;66(1):89-98.
  119. Grey V, Mohammed SR, Smountas AA, et al. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros. 2003;2(4):195-8.
  120. Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of COPD: a systematic review. Eur Respir J. 2006;28(2):330-8.
  121. Hale LP, Greer PK, Trinh CT, James CL. Proteinase activity and stability of natural bromelain preparations. Int Immunopharmacol. 2005;5(4):783-93.
  122. Harlan M. Krumholz, MD; Teresa E. Seeman, PhD; Susan S. Merrill, PhD; Carlos F. Mendes de Leon, PhD; Viola Vaccarino, MD; David I. Silverman, MD; Reiko Tsukahara, MD; Adrian M. Ostfeld, MD; Lisa F. Berkman, PhD. Lack of Association Between Cholesterol and Coronary Heart Disease Mortality and Morbidity and All- Cause Mortality in Persons Older Than 70 Years. JAMA. 1994;272(17):1335-1340. doi:10.1001/jama.1994.03520170045034.
  123. Heggers JP, Cottingham J, Gussman J, et al. The effectiveness of processed grapefruit-seed extract as an antibacterial agent: II
  124. Mechanism of action and in vitro toxicity. J Altern Complement Med. 2002;8(3):333-40.
  125. Huang SH, Schall JI, Zemel BS, Stallings VA. Vitamin E status in children with cystic fibrosis and pancreatic insufficiency.J Pediatr. 2006;148(4):556-559.
  126. Infante P, Redecillas F, Torrent V, et al. Improvement of intestinal function in cystic fibrosis patients using probiotics. An Pediatr. 2008;69(6):501-5.
  127. Jonsdottir B, Bergsteinsson H, Baldursson O. Cystic Fibrosis–Review. Laeknabladid. 2008;94(12):831-7.
  128. Kannel, D’Agostino, Silbershatz, Belanger, Wilson, Levy. ‘Profile for Estimating Risk of Heart Failure’ – Arch Intern. Med. 1999.
  129. Kaati G., Bygren L.O., Pembrey M., Sjostrom M. (2007). Transgenerational response to nutrition, early life circumstances and longevity. European Journal of Human Genetics, 15: 784-790.
  130. Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res. 2006;20(5):424-5.
  131. Kucharski R., Maleszka J., Foret S., Maleszka R. Nutritional Control of Reproductive Status in Honeybees via DNA Methylation (2008). Science, 319: 1827-1830 (registration required)
  132. McCabe H. Riboflavin deficiency in cystic fibrosis: three case reports. J Hum Nutr Diet. 2001;14(5):365-70.
  133. McGowan P.O., Meaney M.J., Szyf M. (2008).  Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Research, 1237: 12-24 (subscription required).
  134. Mizejewski GJ, Pass KA. Fatty acids, alpha-fetoprotein, and cystic fibrosis. Pediatrics. 2001;108(6):1370-3.
  135. Murray KL, Lee CK, Mogayzel PJ Jr, Zeitlin PL, Rosenstein BJ. Dietary supplement use in pediatric patients with cystic fibrosis. Am J Health Syst Pharm. 2008;65(6):562-5.
  136. National Institutes of Health (U.S. Department of Health and Human Services) www.nih.gov.
  137. Nutrition Reviews 54: 1-30, 1996. Raised glutathione levels fight the oxdiation of fats circulating in the bloodstream including cholesterol, retarding the process of plaque formation in the arteries leading to most heart attacks and strokes.
  138. Olveira G, Olveira C. Nutrition, cystic fibrosis and the digestive tract. Nutr Hosp. 2008;23(2):71-86.
  139. Paterson PG, Juurlink BH. Nutritional Regulation of Glutathione in Stroke. Neurtox Res. 1999 Dec; 1(2): 99-112.
  140. Parikh, Pencina, Wang, Benjamin, Lanier, Levy, D’Agostino, Kannel, Vasan. ‘A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study’, Annals of Internal Medicine 2008.
  141. Pencina, D’Agostino, Larson, Massaro, Vasan. ‘Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study’, Circulation 2009.
  142. Proesmans M, Vermeulen F, De Boeck K. What’s new in cystic fibrosis? From trating symptoms to correction of the basic defect. Eur J Pediatr. 2008;167(8):839-49.
  143. RahmanI, MacNee W. Oxidative Stress and Regulation of Glutathione in Lung Inflammation. Eur Respir J. 2000 Sep; 16(3):534-54.
  144. Roum JH, Buhl R, McElvaney NG, et al. Systemic Deficiency of Glutathione in Systic Fibrosis. J Appl Physiol 1993; 75:19-24.
  145. Rubin BK. The pharmacologic approach to airway clearance: Mucoactive agents. Paediatr Respir Rev. 2006;7 Suppl 1:S215-9.
  146. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D’Agostino RB, Sr., Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort Lancet 2009;373:739-745.
  147. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505.
  148. The Adult Treatment Panel III, JAMA. 2001.
  149. Wilson, Meigs, Sullivan, Fox, Nathan, D’Agostino. ‘Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study,’ Archives of Internal Medicine 2007.
  150. Young, RO, Sick and Tired, Woodland Publishing, Orem, Utah, 2001.
  151. Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J. 2005;46(5):585-96.
  152. Young, RO, Young, SR, Young, The pH Miracle Revised and Updated, Grand Central Publishing, New York, NY, 2010Pollak O J. 1952, An Etiologic Concept of Atherosclerosis Based on Study of Intimal Alterations after Shock. Circulation;5;539-550. Full free paper at:http://circ.ahajournals.org/cgi/reprint/5/4/539.pdf
  153. 148. Ross R, Glomset J, Harker L. 1977. Response to injury and atherogenesis. Am J Pathol. Mar;86(3):675-8
  154. Press release. 2006. New Explanation For The Cause Of Atherosclerosis: The Acidity Theory, Medical News Today, Aug 10 at http://www.medicalnewstoday.com/articles/49244.php
  155. Press release. 2006. Beyond Lipids: Understanding the Mechanics of Atherosclerosis (press release). UCSD News, July 12. at: http://www.jacobsschool.ucsd.edu/news/news_releases/release.sfe?id=554
  156. Kaunas R, Usami S, Chien S. 2006 Regulation of stretch-induced JNK activation by stress fiber orientation. Cellular Signalling, Nov;18(11):1924-31 at http://www.ncbi.nlm.nih.gov/pubmed/16581230
  157. Haga JH, Li Yi-Shuan J. and Chien S. 2007. Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells, Journal of Biomechanics, 40(5):947-60.
  158. Mesquita QHde. 1979. Myogenic Theory of Myocardial Infarction (Teoria Miogênica do Enfarte do Miocárdio, Gemini, Sao Paulo, SP – Brazil Book in Portuguese language with a summary in English at: http://www.infarctcombat.org/LivroTM/parte8.htm
  159. Mesquita QHde, Baptista CAS. 1994. Why Myogenic Theory not Thrombogenic Theory. Arq Bras Cardiol, V. 62 (4) – (Official Journal of Brazilian Cardiology Society). Full translated paper at http://www.infarctcombat.org/MTxTT-ABC.pdf
  160. Fernandes VS et al. 2006, Subclinical atherosclerosis and incipient regional myocardial dysfunction in asymptomatic individuals. The Multi-Ethnic Study of Atherosclerosis (MESA), J Am Coll Cardiol 47: 2420-8 Full free paper at http://content.onlinejacc.org/cgi/content/full/j.jacc.2005.12.075v1
  161. Marwah R, Doux J, Lee P and Yun A. 2007. Is atherosclerosis a neurogenic phenomenon? Medical Hypotheses, V 69, I 4: 884-887
  162. Selye H. 1950. The physiology and pathology of exposure to stress: A treatise based on the concepts of the general-adaptation-syndrome and the diseases of adaptation”, Montreal, Acta, Inc. / Selye H et al. 1970 Experimental Cardiovascular Diseases, Volume 1 (History, Cardiovascular Disease, Factors Influencing Cardiovascular Disease); Volume 2 (Histology and Histochemistry, Chemical and Functional Changes, References), Springer-Verlag, Berlin New York
  163. Cannon WJ. 1914. The emergency function of the adrenal medulla in pain and the major emotions. Am J Physiol. 33:356-372
  164. Benson JC, Eckert SP, McCleskey EW. 1999. Acid-Evoked Currents in Cardiac Sensory Neurons – A possible mediator of myocardial ischemic sensation, Circulation Research, 84:921-928. Full free paper at http://circres.ahajournals.org/cgi/content/full/84/8/921
  165. Gianni M et al. 2006. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review, European Heart Journal, V27,N13: 1523-1529
  166. Akashi YJ et al. 2002. Reversible left ventricular dysfunction “takotsubo” cardiomyopathy related to catecholamine cardiotoxicity, J. Electrocardiol 2002; 35:351-356
  167. Arora S et al. 2006. Transient left ventricular apical ballooning after cocaine use; is catecholamine cardiotoxicity the pathologic link? Mayo Clin Proc. 2006; 81:820-832. Full free paper at http://www.mayoclinicproceedings.com/pdf/8106/8106cr2.pdf
  168. Wittstein IS et al. 2005. Neurohumoral features of myocardial stunning due to sudden emotional stress, New Engl J Med, Feb 10, V352: 539-548
  169. Graham LN, Smith PA et al. 2004. Sympathetic neural hyperactivity and its normalization following unstable angina and acute myocardial infarction, Clin Sci (Lond), Jun;106(6):605-11
  170. Gazes PC, Richardson JA et al. 1959. Plasma catecholamine concentrations in myocardial infarction and angina pectoris, Circulation 19:657-661
  171. Waldenstrom AP et al. 1978. A possible role of noradrenaline in the development of myocardial infarction, Am Heart J. 95:43-51
  172. Nadeau RA, de Champlain J. 1979. Plasma catecholamine in acute myocardial infarction, Am Heart J, 98: 548-554
  173. McCance AJ, Thompson PA, Forfar JC. 1993. Increased cardiac sympathetic nervous activity in patients with unstable coronary heart disease, Eur Heart J, Jun;14(6):751-7
  174. Makikalio A. 2005. Cardiovascular autonomic and hormonal dysregulation in ischemic stroke with an emphasis on survival, International Journal of Circumpolar Health 64:5
  175. Korner P. 2007. Essential Hypertension and Its Causes: Neural and Non-Neural Mechanisms. New York, Oxford University Press
  176. Rainforth MV, Schneider RH, Nidich SI, Gaylord-King C, Salerno JW, Anderson JW. 2007. Stress Reduction Programs in Patients with Elevated Blood Pressure: A Systematic Review and Metaanalysis. Curr Hypertens Rep Dec;9(6):520-8. Full free paper at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=18350109
  177. Barnett PA, Spence JD, Manuck SB, et al. 1997. Psychological stress and the progression of carotid artery disease, J Hypertens 15:49–55
  178. Kamarck TW, Everson SA, Kaplan GA, et al. 1997. Exaggerated blood pressure responses during mental stress are associated with enhanced carotid atherosclerosis in middle-aged Finnish men: findings from the Kuopio ischemic heart disease study. Circulation,96:3842–8 Full free paper at: http://circ.ahajournals.org/cgi/content/full/96/11/384210
  179. Jennings JR, Kamarck TW et al. 2004. Exaggerated blood pressure responses during mental stress are associated with enhanced carotid atherosclerosis in middle-aged Finnish men: findings from the Kuopio ischemic heart disease study, Circulation;110:2198-2203. Full free paper at: http://circ.ahajournals.org/cgi/content/full/110/15/2198
  180. Hauss WH et al. 1990. Adrenaline and noradrenaline as possible chemical mediators in the pathogenesis of arteriosclerosis. Ann N Y Acad Sci 598:91-101
  181. Matthews KA et al. 1998. Stress-Induced Pulse Pressure Change predicts women’s carotid atherosclerosis, Stroke 29:1525-1530
  182. Matthews KA, Zhu S, Tucker DC, Whooley MA. 2006. Blood pressure reactivity to psychological stress and coronary calcification in the Coronary Artery Risk Development in Young Adults Study, Hypertension, Mar; 47(3):391-5. Full free paper at http://hyper.ahajournals.org/cgi/content/full/47/3/391
  183. Ghiadone L et al. 2000. Mental stress induces transient endothelial dysfunction in humans, Circulation102:2473. Full free paper at http://circ.ahajounals.org/cgi/content/full/102/20/2473
  184. Steptoe A. et al. 2006. Delayed blood pressure recovery after psychological stress is associated with carotid intima-media thickness. Arterioscler. Thromb. Vasc. Biol. Nov, 26(11):2547-51
  185. Eller NH, Netterstrom. 2007. Psychosocial factors at home and at work and four-years progression in intima-media thickness. In J Behav Med 2007; 14 (1):21-29
  186. Faramawi et al. 2007. Relation between depressive symptoms and common carotid artery atherosclerosis in American persons > 65 years of age, Am J Cardiol; 99:1610-1613
  187. Schoner W. 2002. Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem. 268, 2440-2448, Full free paper at http://www.ejbiochem.org/cgi/content/full/269/10/2440
  188. Nesher M, Shpolansky U, Rosen H, Lichtstein D. 2007.The digitalis-like steroid hormones: New mechanisms of action and biological significance. Life Sci. May 15;80(23):2093-107
  189. Sophocleus A et al. 2003. Circulating endogenous digitalis-like factors (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent. J Endocrinol Invest Jul;26(7):668-74
  190. Weidemann H et al. 2004. Diverse effects of stress and additional adrenocorticotropic hormone on digitalislike compounds in normal and nude mice, Journal of Neuroendocrinology, Vol 16, 458-463. Full free paper at http://physiology.huji.ac.il/pdf/lichtstein/weiden-et-al04.pdf
  191. Hassan M. AM Qazzaz et al. 2004. De Novo Biosynthesis and Radiolabeling of Mammalian Digitalis-Like Factors. Clin Chem. Mar;50(3):612-20. Full free paper at http://www.clinchem.org/cgi/content/full/50/3/612
  192. Rose AM, Valdes RJ. 1994. Understanding the sodium potassium pump and its relevance to disease, Clin. Chem. 40/9: 1674-1685 Full free paper at: http://www.clinchem.org/cgi/reprint/40/9/1674
  193. Vasilyev A, Khater K, and Rakowski RF. 2004. Effect of Extracellular pH on Presteady-State and SteadyState Current Mediated by the Na+/K+ Pump,. J Membr Biol. March 15; 198(2):65–76. Full free paper at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1357233
  194. Li C, Geering K, Horisberger JD. 2006. The Third Sodium Binding Site of Na,K-ATPase Is Functionally Linked to Acidic pH-Activated Inward Current. Membr Biol. 213(1):1-9.
  195. Mesquita QHde, Baptista CAS. 2002. Cardiotônico: insuperável na preservação da estabilidade miocárdica como preventivo das síndromes coronárias agudas e responsável pela prolongada sobrevida, Ars Cvrandi, maio 35:3. Full free paper at http://www.infarctcombat.org/28anos/digitalicos.html . Summary in English at: http://www.infarctcombat.org/heartnews-16.html
  196. Mesquita QHde, Baptista CAS et al. 2002. Efeitos do cardiotônico + dilatador coronário na coronáriomiocardiopatia crônica estável, com e sem enfarte prévio, a longo prazo. Ars Cvrandi, setembro;35:7. Full free paper at http://www.infarctcombat.org/qhm/cme.pdf Summary in English athttp://www.infarctcombat.org/heartnews-16.html
  197. Kern B. 1970. Der Myokard-Infarkt. Haug-Verlag, Heidelberg.
  198. Gao JRS et al. 2002. Isoform specific stimulation of cardiac Na/K pumps by nM concentrations of glycosides, J Gen Physiol 119:297-312. Full free paper at http://www.jgp.org/cgi/content/full/119/4/297
  199. Schobel HP et al. 1991.Contrasting effects of digitalis and dobutamine on baroreflex sympathetic control in normal humans, Circulation V84, 1118-1129. Full free paper at: http://circ.ahajournals.org/cgi/reprint/84/3/1118
  200. Gutman Y, Boonyaviroj P. Naunyn Schmiedebergs. 1977. Mechanism of inhibition of catecholamine release from adrenal medulla by diphenylhydantoin and by low concentration of ouabain (10 (-10) M). Arch Pharmacol Feb;296(3):293-6
  201. von Ardenne M. 1978. Die Hemmung der mikrozirculation beim myokardinfarkt und das perlingual applizierte g-strophanthin, Arzneimittel-Forsch. 28; 202:
  202. Pierre SV et al. 2007. Ouabain triggers preconditioning through activation of the NA+, K+-ATPase signalling cascade in rat hearts, Cardiovasc Res, Feb 1;73(3): 488-96
  203. Pugin J, Dunn-Siegrist I, Dufour J, Tissieres P, Charles PE, Comte R. 2007. Cyclic Stretch of Human Lung Cells Induces an Acidification and Promotes Bacterial Growth, Am J Respir Cell Mol Biol. Oct 5 doi:10.1165/rcmb.2007-0114OC
  204. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. 2005. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet. Mar 5-11;365(9462):871-5.
  205. Schade DS.1982. The role of catecholamines in metabolic acidosis. Ciba Found Symp;87:235-53
  206. Abarquez RF Jr. 1967. Digitalis in the treatment of hypertension. A preliminary report. Acta Med Philipp. Jan-Mar;3(3):161-70
  207. Yuan CM, Manunta P, Hamlyn JM et al. 1993. Long-term ouabain administration produces hypertension in rats. Hypertension, 3;22;178-187 Full free paper at:  http://hyper.ahajournals.org/cgi/reprint/22/2/178
  208. Manunta, P., Hamilton, J., Rogowski, A.C., Hamilton, B.P., Hamlyn, J.M. 2000. Chronic hypertension induced by ouabain but not digoxin in the rat:antihypertensive effect of digoxin and digitoxin. Hypertension Research 23 (Suppl), S77–S85.
  209. Yang Q, Huang W, Jozwik C, Lin Y, Glasman M et al. 2005. Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc Natl Acad Sci USA Jul 5;102(27):9631-6. Full free paper at http://www.pnas.org/cgi/content/full/102/27/963111
  210. Sternberg EM. 2001. Neuroendocrine regulation of autoimmune/inflammatory disease, J Endocrinol Jun; 169(3):429-35. Full free paper at http://joe.endocrinology-journals.org/cgi/reprint/169/3/429
  211. Brum PC, Kosek J, Patterson A et al. 2002. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol 283: H1838-H1845. Full free paper at http://ajpheart.physiology.org/cgi/content/full/283/5/H1838#B4
  212. F. E. Demartini, P. J. Cannon, W. B. Stason, and J. H. Laragh. 1965. Lactic Acid Metabolism in Hypertensive Patients. Science 11 June, Vol. 148. no. 3676, pp. 1482 – 1484
  213. Sharda S, Gupta SN and Khuteta KP. 1975. Effect on mental stress on intermediate carbohydrate-and lipidmetabolism. Indian J Physiol Pharmacol. Apr-Jun;19(2):86-9.
  214. Hall JB, Brown DA. 1979. Plasma glucose and lactic acid alterations in response to a stressful exam. Biol Psychol. May;8(3):179-88.
  215. von Ardenne M, Reitnauer PG. 1989. Increase of perfusion pressure at constant perfusion rate caused by low pH values, Biomed Biochim Acta, 48(4):317-23
  216. Yasushi Horai et al. 2005. Changes in pH increase perfusion pressure of coronary arteries in the rat. J Pharmacol Sci 97; 400: 407
  217. Austin C, Wray S. 2000. Interactions Between Ca2+ and H+ and Functional Consequences in Vascular Smooth Muscle, Mini Review, Circulation Research 86:355. Full free paper at: http://circres.ahajournals.org/cgi/content/full/86/3/355
  218. Kim YM et al. 2005. Contribution of Na_-K_ pump and KIR currents to extracellular pH-dependent changes of contractility in rat superior mesenteric artery, Am J Physiol Heart Circ Physiol 289:792-800 Full free paper at http://ajpheart.physiology.org/cgi/reprint/289/2/H792
  219. Carter G, Gavin JB. 1989. Endocardial damage induced by lactate, lowered pH and lactic acid in nonischemic beating hearts. Pathology Apr;21(2):125-30
  220. Sharma AM, Kribben A et al. 1990. Salt sensitivity in humans is associated with abnormal acid-base balance. Hypertension; 16, 407-413. Full free paper at http://hyper.ahajournals.org/cgi/reprint/16/4/407
  221. Harold T. Edwards, Edward H. Bensley, David B. Dill and Thorne M. Carpenter. 1944. Human Respiratory Quotients in Relation to Alveolar Carbon Dioxide and Blood Lactic Acid After Ingestion of Glucose, Fructose, or Galactose. Journal of Nutrition Vol. 27 No. 3 March, pp. 241-251. Full free paper at http://jn.nutrition.org/cgi/reprint/27/3/241
  222. Hallfrisch J. 1990. Metabolic effects of dietary fructose. FASEB J, Vol 4; Jun: 2652-2660. Full free paper at http://www.fasebj.org/cgi/reprint/4/9/2652.pdf
  223. Mesquita QHde. 1982. Aspectos angiográficos coronários e ventriculograficos do primeiro enfarte do miocárdio em coronariopatia crônica silenciosa. Rev. Bras. Med., V 39: N7
  224. LA Naves and McCleskey EW. 2005. An acid-sensing ion channel that detects ischemic pain. Braz J Med Biol Res, 38 (11) 1561-69 http://www.scielo.br/pdf/bjmbr/v38n11/v38n11a01.pdf
  225. Vogt AM, Ackermann C, Yildiz M, Schoels W, Kübler W. 2002. Lactate accumulation rather than ATP depletion predicts ischemic myocardial necrosis: implications for the development of lethal myocardial injury, Biochim Biophys Acta Mar 16;1586(2):219- 26.
  226. Todd GL, Baroldi G, Pieper GM, Clayton FC, Eliot RS. 1985. Experimental catecholamine- induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions. J Mol Cell Cardiol. Apr 17(4):317- 38.
  227. Henning RJ, Well MH, Weiner F. 1982. Blood lactate as prognostic indicator of survival in patients with acute myocardial infarction. Circ Shock, 9(3):307-15
  228. Vikhert AM, Cherpachenko NM. 1985. Histoenzymological characteristics of the myocardium in sudden cardiac death. Arkh Patol 47(7):29-34
  229. Huang Y, McNamara JO. 2004. “Ischemic Stroke: “Acidotoxicity” Is a Perpetrator”, Cell, Volume 118, Issue 6, 17 September, Pages 665-666Tennant R. 1935. Factors concerned in the arrest of contraction in an ischemic myocardial area. Am J Physiol: 133; 677-682
  230. Katz AM, Hecht H. H. 1969. The early pump failure of the ischaemic heart. Am J Med: 47; 497-502
  231. Elharrer V, Zipes D.P. 1977. Cardiac electrophysiologic alterations during myocardial ischaemia. Am J Physiol: 233: H329-345
  232. Pan HL et al. 1999. Role of protons in activation of cardiac sympathetic C-fibre afferents during ischaemia in cats. J Physiol. Aug 1;518 ( Pt 3):857-66. Full free paper at http://jp.physoc.org/cgi/content/full/518/3/857
  233. Leake DS. 1997. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions? Atherosclerosis. Mar 21;129(2):149- 57
  234. Gown MA, Benditt PE. 1982. Lactate dehydrogenase (LDH) isozymes of human atherosclerotic plaques. Am J Pathol 1982, 107:316-321
  235. Morgan J, Leake DS. 1995. Oxidation of low density lipoprotein by iron or copper at acidic pH. J Lipid Res. Dec;36(12):2504- 12. Full free paper at: http://www.jlr.org/cgi/reprint/36/12/2504
  236. Patterson RA, Leake DS. 1998. Human serum, cysteine and histidine inhibit the oxidation of low density lipoprotein less at acidic pH. FEBS Lett. Sep 4;434(3):317- 21.
  237. Naghavi M et al. 2002. pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atherosclerosis Sep, V 164; 1:27-35
  238. Khan T, Soller B, Naghavi M, Casscells W. 2005. Tissue pH determination for the detection of metabolically active inflamed vulnerable plaques using near-infrared spectroscopy: an in-vitro feasibility study. Cardiology.; 103(1): 10-6.
  239. Sneck M, Kovanen PT, Oorni K. 2005. Decrease in pH strongly enhances binding of native, proteolysed, lipolysed, and oxidized low density lipoprotein particles to human aortic proteoglycans, Journal of Biological Chemistry, 280;45: Nov. Full free paper at http://www.jbc.org/cgi/reprint/280/45/37449
  240. Oorni K and Kovanen PT. 2006. Enhanced extracellular lipid accumulation in acidic environments. Curr Opin Lipidol 17(5);534-40: Oct
  241. Patterson RA, Horsley ETM, Leake DS. 2003. Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. Journal of Lipid Research, Vol. 44, 512-521, March Full free paper at http://www.jlr.org/cgi/reprint/44/3/51212
  242. Hayden MR, Tyagi SC. 2004. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond). 1: 10, October 19. Full paper at http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=529248
  243. McCully KS. 1969. Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis. Am J Pathology 56:111:28
  244. Stoney CM. 1999. Plasma homocysteine levels increase in women during psychological stress, Life Sci 64(25):2359-65
  245. Stoney CM and Engebretson TO. 2000. Plasma homocysteine concentrations are positively associated with hostility and anger, Life Sci 66(23):2267-75
  246. Hapuarachchi JR, Chalmers AH et al. 2003. Changes in clinically relevant metabolites with psychological stress parameters. Behav Med. Summer;29(2):52-9
  247. Jerlich A et al. 1999. Correlation of low-density lipoprotein modification by myeloperoxidase with hypocholorous acid formation, Int. J. Clin, Lab, Res 29(4):155-61
  248. Podrez EA, Abu-Soud HM, Hasen SL. 2000. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28:1717–172
  249. Yang J, Cheng Y, Ji R, Zhang C. 2006. Novel model of inflammatory neointima formation reveals a potential role of myeloperoxidase in neointimal hyperplasia. Am J Physiol Heart Circ Physiol. Dec;291(6):H3087- 93.
  250. Meuwese MC, Stroes ESG, Hazen SL, et al. 2007. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: The EPIC-Norfolk Prospective Population Study..J Am Coll Cardiol 50:159-165
  251. Wong ML et al. 2000. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis, PNAS 97;8681-8686 Full free paper at http://www.pnas.org/cgi/content/full/97/15/8681
  252. Abela GS. 2006. Plaque Rupture by Cholesterol Crystallization – A Novel Concept for Acute Coronary Syndrome, American College of Cardiology Annual Scientific Session, March 13, Full free paper at http://www.cardiosource.com/rapidnewssummaries/summary.asp?SumID=164
  253. Malek AM, Alper SL, Izumo S. 1999. Hemodynamic shear stress and its role in atherosclerosis JAMA 282: 2035-2042
  254. Cheng C et al. 2006. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 113:2744-2753. Full free paper at at: http://circ.ahajournals.org/cgi/content/abstract/113/23/2744
  255. Cunningham KS and Gotlieb AI. 2005. The role of shear stress in the pathogenesis of atherosclerosis (Mini review), Laboratory Investigation 85, 9-23, Full free paper at: http://www.nature.com/labinvest/journal/v85/n1/full/3700215a.html
  256. Texon M. 1957. A hemodynamic concept of atherosclerosis, with particular reference to coronary occlusion. Arch Intern Med 99:418–42
  257. Imparato AM, Lord JW Jr, Texon M, Helpern M. 1961. Experimental atherosclerosis produced by alteration of blood vessel configuration. Surg Forum 12:245–247.
  258. Rittersma SZH, van der Wal AC, Koch KT, et al. 2005. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis. A pathological thrombectomy study in primary percutaneous coronary intervention. Circulation; 111:1160-1165. Full free paper at: http://circ.ahajournals.org/cgi/content/full/111/9/1160
  259. Ojio S, Takatsy H, et al. 2000. Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans coronary angiographic findings within 1 week before the onset of infarction. Circulation;102:2063. Full free paper at:http://www.circ.ahajournals.org/cgi/reprint/102/17/206
  260. Ulrich E. Heidlan, Bodo E. Strauer. 2001. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption, Circulation 104:1477. Full free paper at: http://circ.ahajournals.org/cgi/content/full/104/13/1477
  261. Baroldi G, Bigi R, Cortigiani L. 2004. Ultrasound imaging versus morphopathology in cardiovascular diseases. Coronary collateral circulation and atherosclerotic plaque. Cardiovascular ultrasound; 3: 6. Full free paper at: http://www.cardiovascularultrasound.com/content/3/1/6
  262. Roberts W. C. 1974. Coronary Thrombosis and Fatal Myocardial Ischemia. Circulation;49;1-3 Full free paper at http://circ.ahajournals.org/cgi/reprint/49/1/1.pdf
  263. Rioufol G, Finet G, Andre-Fouet X et al. 2002. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation; 106:804-808. Full free paper at: http://www.circ.ahajournals.org/cgi/reprint/01.CIR.0000025609.13806.31v1
  264. Yasunori Ueda, Masanori Asakura, et al. 2001. The healing process of infarct-related plaque: Insights from 18 months of serial angioscopic follow-up. Am Coll Cardiol, 38:1916-1922.Full free paper at: http://content.onlinejacc.org/cgi/reprint/38/7/1916
  265. Giorgio Baroldi, Riccardo Bigi and Lauro Cortigiani.2005. Ultrasound imaging versusmorphopathology in cardiovascular diseases. Myocardial cell damage. Cardiovascular Ultrasound 3:32. Full free paper at http://www.cardiovascularultrasound.com/content/3/1/32
  266. Murakami T, Mizuno S, Takahashi Y, Ohsato K et al. 1998. Intracoronary aspiration thrombectomy for acute myocardial infarction, Am. J Cardiology Oct 1;82 (7):839-44
  267. Wang HX, Leineweber C, et al. 2007. Psychosocial stress and atherosclerosis: family and work stress accelerate progression of coronary disease in women. The Stockholm Female Coronary Angiography Study. Journal of Internal Medicine 261;245-254
  268. Richmond AC et al. 2000. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans, Stroke 31:568-573. Full free paper at: http://stroke.ahajournals.org/cgi/reprint/31/3/568
  269. Fields JZ et al. 2002. Effect of a multimodality natural medicine program on carotid atherosclerosis in older subjects: a pilot trial of Maharishi Vedic Medicine, American Journal of Cardiology, 89; 8:952-958
  270. Manchanda SC, Narang R, Reddy KS, Sachdeva U, Prabhakaran D, Dharmanand S, Rajani M and Bijlani R. 2002. Retardation of coronary atherosclerosis with yoga lifestyle prevention, J Assoc Physicians India Jul; 48(7): 687-94 13.
  271. Rainer Rauramaa et al. 2004. Effects of aerobical physical exercise on inflammation and atherosclerosis in men: The DNASCO Study. Annals of Internal Medicine, 15 June, 140:12:1007-1014,
  272. Lichtor T et al. 1987.The sympathetic nervous system and atherosclerosis. J Neurosurg Dec;67(6):906-1,Pauletto P et al. 1991. Sympathetic drive and vascular damage in hypertension and atherosclerosis, Hypertension Apr;17(4 Suppl):III75-81.
  273. Wikstrand J, Berglund G, Hedblad B, Hulthe, Wikstrand J. 2003.Anti-atherosclerotic effects of beta-blockers. Am J Cardiol. Jun 19;91(12A):25H-29H.
  274. Sipahi I et al. 2007. B-Blockers and progression of coronary atherosclerosis; Pooled analysis of 4 intravascular trials. Annals of Internal Medicine, 3 July, V147; Issue 1: 10-18
  275. Mesquita QHde, Kerbrie SV, Mari SM, Baptista CA, Monteiro J, Maciel MC. 1978. Preservação funcional do miocárdio isquêmico pelo cardiotonico a longo prazo: recateterização de 29 casos. Medicina de Hoje, março 1978
  276. Hansson GK. 2005. Inflammation, atherosclerosis and coronary artery disease, NEJM V 352; N16 April 21.
  277. Malcolm Kendrick. 2007. Are statins overused? Future Lipidol, 2 (5)
  278. Player MS, King DE, et al. 2007. Psychosocial Factors and Progression From Prehypertension to Hypertension or Coronary Heart Disease, Ann Fam Med ;5(5):403-411. Full free paper at http://www.medscape.com/viewarticle/565806?src=mp.
  279. Palatini P, Longo D, Zaetta V, Perkovic D, Garbelotto R, Pessina AC. 2006. Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity, J Hypertens.Jul;24(7):1375-81.
  280. Grassi G, Quarti-Trevano F, Seravalle G, Dell’Oro R. 2007. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutr Metab Cardiovasc Dis Jul; 17(6): 473-81.
  281. Choi CS, Kiim YB, Lee FN, et al. 2002. Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling. Am J Physiol Endocrinol Metab 283: E233–E240, 2002. Full free paper at: http://ajpendo.physiology.org/cgi/content/full/283/2/E233,
  282. Tentolouris N, Tsigos C, Perea D et al. 2003. Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women. Metabolism. Nov;52(11):1426- 32.
  283. Calynn Davis Bunol, 2005. Thesis, Autonomic nervous system modulation of the heart following a high carbohydrate liquid meal, December. Full free paper at http://etd.lsu.edu/docs/available/etd-09082005-165133/unrestricted/Bunol_thesis.pdf
  284. Erkilla AT, Matthan NR, et al. 2006. Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD. J Lipid Res; 47: 2814-19 Full free paper at http://www.jlr.org/cgi/reprint/47/12/2814.
  285. Ogilve GK, Fettman MJ et al. 2000. Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: A double-blind, randomized placebo-controlled study, Cancer; 88: 1016-28. Full free paper at: http://www3.interscience.wiley.com/cgibin/fulltext/75504731/PDFSTART
  286. Graziani Y. 1977. Regulation of cyclic AMP level and lactic acid production in Ehrlich ascites tumor cells. Biochim Biophys Acta April 27;497(2):499-506.
  287. Nazam Ansari N, Bhandari U, Pillai KK. 2007. Protective role of curcumin in myocardial oxidative damage induced by isoproterenol in rats. Hum Exp Toxicol, Dec;26(12):933-8.
  288. Dernek S et al. 2004. Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in heart rats after global ischemia. Scand Cardiovasc J Aug;38(4):245-54.
  289. Al Makdessi S, Sweidan H, Müllner S, Jacob R. 1996. Myocardial protection by pretreatment with Crataegus oxyacantha: an assessment by means of the release of lactate dehydrogenase by the ischemic and reperfused Langendorff heart. Arzneimittelforschung Jan;46(1):25-7.
  290. Leor J, Goldbourt U et al. 1995. Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose, Cardiovasc Drugs Ther. Oct;9(5):723-
  291. Adams KF Jr, Patterson JH et al. 2005. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol. Aug 2;46(3):497-504.
  292. Wycoff C.C. 1969. New Concepts of Digitalis, Calif Med. 1969 December; 111(6): 423–432. Full free paper at http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1503737.
  293. T Bjornheden, M Levin, M Evaldsson, O Wiklund. 1999. Evidence of hypoxic areas within the arterial wall in vivo, Arteriosclerosis, Thrombosis and Vascular Biology; 19:870-87.
  294. Quick AJ. 1935. The effect of exercise on the excretion of uric acid. The Journal of Biological Chemistry. Full free paper at: http://www.jbc.org/cgi/reprint/110/1/107.pdf
  295. Flierl MA, Rittirsch D, Nadeau BA et al. 2007. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature Oct 11;449 (7163):721-5
  296. Lee KS and Klaus W. 1971. The subcellular basis for the mechanisms of inotropic action of cardiac glycosides. Pharmacol Rev 23:193-261
  297. Wen Y, Leake DS. 2007. Low density Lipoprotein oxidation undergoes within lysosome in cells. Circ.Res. 100;1337-1343. Full free paper at http://circres.ahajournals.org/cgi/content/full/100/9/1337
  298. Marshall MW and Iacono JM (1976). Changes in lactate dehydrogenase, LDH isoenzymes, lactate, and pyruvate as a result of feeding low fat diets to healthy men and women. Metabolism. 1976 Feb;25(2):169-78.
  299. Yoshimura T, Miyoshi T, et al. (1986). Effect of high carbohydrate diet on serum lactate
  300. dehydrogenase isozyme pattern in Japanese young men. Acta Biol Hung. 1986;37(3-4):243-8.
%d bloggers like this: